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Zusammenfassung 
In der vorliegenden Arbeit wurden permeabilisierte Zellen als Ganzzellbiokatalysator 
verwendet. Bei der Permeabilisierung werden Zellen mit Detergenzien behandelt, wodurch 
die Zellhülle für kleine Moleküle durchlässig wird. Die Zellen bleiben dabei makroskopisch 
intakt, und Makromoleküle wie etwa Enzyme verbleiben in den Zellen. Die so erhaltenen 
„Enzymbeutel“ werden als Katalysator eingesetzt. Mittels permeabilisierter E. coli wurde 
UDP-Glukose mit einer Ausbeute von 60% aus Uridinmonophosphat synthetisiert. Die 
verwendeten Zellen wurden mit dem Detergenz Triton X-100 permeabilisiert. Das für die 
Synthese benötigte ATP wurde regeneriert und Glukose-1-Phosphat wurde mittels Sucrose 
Phosphorylase aus Saccharose gewonnen. Das Sucrose Phosphorylase Gen wurde heterolog 
eingebracht.  
Weiterhin wurde ein S. pombe Stamm, welcher das humane UDP-Glukose Dehydrogenase 
Gen exprimiert, zur Synthese von UDP-Glukuronsäure, verwendet. Auch dieser Organismus 
konnte mit Triton X-100 permeabilisiert werden. Es wurde eine Ausbeute von 100% erzielt. 
Ein E. coli Nissle Stamm, welcher den plu3263 Gencluster aus Photorhabdus luminescens 
beherbergt, wurde zur Synthese von Luminmiden, zyklischen, nicht ribosomal synthetisierten 
Pentapeptiden, verwendet. Hier war Toluol bei der Permeabilisierung der Zellen am 
effektivsten. Es wurden scheinbare kinetische Parameter für die Bildung des Hauptproduktes 
berechnet. Weiterhin wurden einige natürliche und ein nicht natürliches Luminmid Derivate 
synthetisiert.  
 
 
 
 
 
Abstract 
In the presented thesis permeabilized cells were used as whole cell biocatalyst. During 
permeabilization cells are treated with detergents causing the cell envelope to become 
permeable to small molecules. During this process, the macroscopic cell structure remains 
intact and macromolecules such as enzymes stay within the cell. After permeabilization and 
removal of metabolites the resulting “enzyme bags” are used as catalyst.  
Permeabilized E. coli cells were applied to synthesize UDP-glucose. The cells were treated 
with the detergent Triton X-100 for permeabilization. UDP-glucose was synthesized from 
uridine monophosphate with 60% yield. ATP was regenerated and glucose-1-phosphate was 
synthesized from sucrose after introduction of the sucrose phosphorylase gene. 
Furthermore, an S. pombe strain expressing the human UDP-glucose dehydrogenase gene was 
applied to synthesize UDP-glucuronic acid. This organism was permeabilized with Triton X-
100 as well. Product yield was 100% when UDP-glucose and NAD
+
 were used as substrates. 
An E. coli strain harboring the plu3263 gene cluster from Photorhabdus luminescens was 
used for the synthesis of luminmide type cyclic pentapeptides, belonging to the class of 
nonribosomally biosynthesized peptides (NRP). Cells were fully permeabilized using toluene. 
Apparent kinetic parameters for the synthesis of the main product, luminmide A, were 
determined. Additionally, several natural and a non-natural luminmides were synthesized.  
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I. Introduction 
 
The following chapter is based on the review article “Directed multi-step biocatalysis using 
tailored permeabilized cells” (Heinzle et al. 2013) published in volume 137 of the series 
“Advances in Biochemical Engineering/Biotechnology” 
1. General introduction 
In billions of evolutionary steps, nature developed an impressive set of strategies to create 
molecules with a wide range of structures. Nearly every carbon, nitrogen, oxygen or sulfur 
containing skeleton and functional group can be assembled in principle by bioconversions. A 
large number of different enzymatically catalyzed reactions support cellular growth and 
survival (Lopez-Gallego and Schmidt-Dannert 2010). Not only the substrate and reaction 
specificity but also the efficiency of enzymatic reactions are usually far beyond man-made 
chemical processes. Recent developments in biochemical research not only support a detailed 
mechanistic understanding of relationship of structure and reactivity, but they also allow 
extended targeted redesign and modification of enzymes. Even completely new functionalities 
can be designed and created with modern molecular and modelling tools (e.g. Diels-Alder 
synthesis with a de novo designed enzyme) (Siegel et al. 2010). The development and present 
status concerning biocatalysis—mostly based on engineered single enzymes—have been 
reviewed thoroughly elsewhere (Siegel et al. 2010)). Recent developments in the field of 
metabolic network research, both experimentally as well as computationally, open up new 
potentials for multistep biocatalysis both in vivo as well as in vitro.  
Presently, slightly more than 100 commercial applications use enzymes in industrial-scale 
processes (Liese et al. 2000). Due to the usually high price, the time required for improving 
enzymes genetically, the often shorter development times required for organic chemistry 
alternatives, and the still widespread ignorance of biocatalysis in the field of organic 
chemistry, bioconversion processes are often not considered (Wohlgemuth 2011). There is, 
however, a trend towards biotechnological processes as the ecological impact (E-factor) of 
industrial productions is gaining weight and public pressure demands a sustainable industry 
(Aehle 2004; Drauz and Waldmann 2012; Heinzle et al. 2006; Wohlgemuth 2010). 
Biocatalytic processes often have a very low ecological impact, such as with selective 
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oxidation of carbohydrates (Schneider et al. 2012), but in some cases chemical alternatives are 
similar or even better (Kuhn et al. 2010). 
Although in vivo synthesis using whole, viable microorganisms provides complex products 
from simple and cheap raw materials by fermentation, it is limited by the fitness and 
tolerance of the organism and by cellular transport processes. Modern metabolic engineering 
methods provide a whole toolbox comprising computational and molecular tools for directed 
design and optimization of production pathways. In most cases, these allow the conversion 
of a poorly producing native organism into a highly efficient producer strain. However, 
transport barriers, bottlenecks in the metabolism, toxic side effects, and the usually required 
complex downstream processing of resulting mixtures of product and growth medium limit 
the industrial applications (Fig. I- 1, Case C).  
 
 
 
 
Figure I-1. Types of multistep biosynthetic processes. A Synthesis using multiple enzymes in 
separate processes, B Synthesis with all enzymes reacting in one-pot, C In vivo synthesis using 
living cells in fermentation processes, D In situ synthesis using permeabilized cells. 
 
In vitro synthesis, on the other hand, serves as a biotechnological alternative to the classic 
chemical catalysts. Engineered for the highest activity, stability, and substrate spectrum, 
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enzymes provide the highest turnover rates, simultaneously working with outstanding 
selectivity (Bornscheuer et al. 2012). However, in case of complex syntheses, the use of 
enzymes is restricted by required optimal conditions for each enzyme and potential 
intermediate clean-up or buffer change between individual steps (Fig. I-1, Case A). 
Additionally, the regeneration of cofactors, such as nicotinamide adenine dinucleotide 
phosphate [NAD(P)H], limits this type of application. A further alternative is the one-pot 
synthesis using multiple enzymes; however, they require extended optimization of enzymes to 
operate at the same pH and buffer concentrations (Fig. I-1, Case B). This approach can also 
be taken using cell hydrolysates of suitable strains, as has been reviewed elsewhere (You and 
Zhang 2013). On the other hand, various approaches use synthetic assemblies of enzymes, 
such as in emulsions, using scaffolds, tethering to surfaces, or covalent binding to achieve 
one-pot synthesis biocatalysis (Moses et al. 2013). Applying cell free biology, proteins have 
been assembled (cell free protein synthesis CFPS). Additionally, isoprenoids, cyclic peptides 
and several drug metabolites have been produced using specifically designed, cell free 
pathways (Dudley et al. 2015; Harris and Jewett 2012). 
Yet another strategy uses permeabilized cells—often called in situ synthesis (Fig. I-1, Case 
D). Permeabilized cell membranes allow diffusion of low-weight compounds between the 
intracellular space and the surrounding reaction buffer while large biopolymers (i.e. proteins 
and DNA) remain trapped inside the microenvironment of the cell. Contrary to using cell 
hydrolysates, which has a very long tradition (You and Zhang 2013), optimal 
permeabilization will keep the enzymes in their native macromolecular environment and not 
cause any denaturation of enzymes by the permeabilizing agent. In this way, the 
macromolecular crowding effects that are expected to modify protein activities (Minton 
2006), such as channeling (Monti et al. 2009) are preserved in their original status. Removing 
all small metabolites and cofactors represents a kind of reset of the metabolic network, 
permitting directed conversions by the selection of appropriate substrate combinations. In 
general, this can be combined with careful tailoring of the enzymatic outfit of a cell, thus 
increasing selectivity of bioconversion using permeabilized cells. Network changes may 
involve gene deletions, gene amplification, or heterologous gene expression. Additionally, 
selective inhibitors might be used to block undesired side reactions (Krauser et al. 2012). An 
interesting alternative concept (Ye et al. 2012) uses enzymes from thermophilic organisms 
that are expressed in a mesophilic organism. Cells are cultivated and then heated to rupture 
the cells and inactivate enzymes that are not desired for the in vitro biocatalytic conversion. 
The opportunities provided by synthesis with permeabilized whole cells for the production of 
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pharmaceuticals and fine chemicals will be highlighted in this chapter. The term ‘‘in situ 
synthesis’’ was introduced in the early 1960s, indicating that macromolecules remain in their 
original intracellular environment. Prokaryotic and eukaryotic cells can be permeabilized, but 
the permeabilization procedure depends on the composition of the cell wall and has to be 
optimized for each cell type. Early studies on permeabilized cells by Felix showed promising 
results. Felix concluded that permeabilized cells can be produced quickly and simply and can 
be used several times, thus requiring less energy for the synthesis of biomass (Felix 1982). 
These studies on synthesis with permeabilized cells never achieved appropriate 
acknowledgment, however—likely because of the missing genetic and metabolic engineering 
tools at that time. The available tools have dramatically changed since then, and it seems 
obvious that synthesis with permeabilized cells will provide an alternative method, thus 
closing the gap between in vivo and in vitro biosynthesis. 
The enormous increase in DNA sequencing power has recently created an overwhelming 
wealth of genome and metabolic network information of a large number of single 
(micro)organisms but also of microbial habitats using metagenome analysis. In parallel, 
computational tools for handling and exploring this vast amount of data have been developed 
at a high rate. However, detailed biochemical knowledge of enzyme characteristics is lagging 
far behind. Nevertheless, genome and enzyme databases provide an enormous amount of data 
that may be explored for permeabilized cell synthesis. Whole genome metabolic networks 
become increasingly available—a few of them already carefully curated. Metabolic regulation 
is also increasingly explored, but it requires considerably higher effort compared to 
sequencing. For some microorganisms, such as Escherichia coli and Saccharomyces 
cerevisiae, metabolic and regulatory networks are already fairly well understood, but we are 
still quite far away from the comprehensive understanding required for creating fully 
predictive models. This is even more the case for the majority of microorganisms. The 
metabolism of microorganisms may differ considerably. Nevertheless, they all share large 
parts of their central metabolism, particularly the 12 small precursor molecules representing 
the bottleneck of the bow-tie-shaped structure of metabolic networks (Ma and Zeng 2003). 
These precursor molecules serve as starting materials for all building blocks and polymers 
that can be synthesized in the metabolic network (Fig. I-2). Although biopolymers constitute 
the major fraction of cellular biomass, secondary metabolites are of great interest as 
pharmaceutically active compounds or precursors thereof. 
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Figure I-2. Overall structure of metabolism. 
 
With the present knowledge, molecular and computational methods, and the advent of new 
possibilities of designing and engineering enzymes and whole metabolic pathways, a large 
field of applications opens up. Together with the long- known technique of permeabilization 
of cellular barriers (i.e. cell membranes and cell walls), new and intriguing opportunities for 
designing tailored biocatalysts and bioprocesses become accessible. Once such a biocatalyst 
is established, it can be produced easily by simple cultivation followed by permeabilization. 
Downstream processing would simply start with the removal of the biocatalyst, such as by 
centrifugation. There are, however, major hurdles to be overcome as far as more complex 
biosynthesis is concerned. The most important are the supply of precursors and cosubstrates, 
such as adenosine triphosphate (ATP) or NAD(P)H; the achievement of selective 
biocatalysts, meaning the elimination of the manifold possible undesirable side reactions; and 
the intensification of processes to obtain high final product concentrations. To reach these 
goals, it is important to understand (i) the permeabilization process on a molecular basis, (ii) 
biosynthetic pathways and their regulation, (iii) supply of precursor molecules, (iv) 
regeneration of cosubstrates, (v) design and selection of enzymes as part of the biosynthetic 
processes, and (vi) design of biocatalytic pathways on the basis of the vast genomic and 
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biochemical knowledge. Some principles of these points will be discussed, particularly the 
permeabilization process and the design of biocatalytic pathways.  
 
2. Permeabilization 
2.1 Lipids and membrane structures 
 
All cells are confined by envelope structures that create cellular compartments, which allow a 
controlled interior separated from the surrounding environment. Although the diversity of 
these structures is huge, they share common elements, such as lipids and integral membrane 
proteins, which constitute the core structures of membranes that are often linked to additional 
carbohydrate and protein structural elements. 
As shown in Figure I-3, there are two major classes of bacterial envelopes. Gram-positive 
organisms have a thick layer of peptidoglycan as the main compound of their cell wall, 
providing them with great mechanical stability. Gram-negative organisms have an additional 
 
 
Figure I-3. Cell envelopes of gram-positive and gram- negative bacteria. CAP covalently attached 
protein, IMP integral membrane protein, LP lipoprotein, LPS lipopolysaccharide, LTA 
lipoteichoic acid, OMP outer membrane protein, WTA wall teichoic acid. Adapted from (Silhavy 
et al. 2010). 
 
outer membrane, which protects the cell by preventing nonpolar toxic substances from 
entering. Compared to the cell membrane, it is less selective and more permeable to small 
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molecules (Vaara 1992). Yeast cells also have a robust cell wall (Fig. I-4), characterized by a 
strongly branched glucan layer. Due to the robustness of their cell wall structures, yeast and 
bacteria have great mechanical stability, which they often preserve after permeabilization 
(Abraham and Bhat 2008; Cánovas et al. 2005; Yuan and Heinzle 2009). This facilitates the 
handling and especially the washing of these cells. Most permeabilization methods disturb or 
partly disrupt the cellular membranes while leaving the remaining cell wall structures largely 
intact in most cases (Abraham and Bhat 2008; Malik et al. 2012; Zhang et al. 2006b). For this 
reason, bacterial and yeast cells preserve their macroscopic shape and dimensions after 
permeabilization. Although it does not block the passage of small molecules, the remaining 
cell envelope largely prevents the diffusion of cytosolic enzymes into the surrounding 
medium (Kaur et al. 2009; Sestak and Farkas 2001; Tryfona and Bustard 2008). At the same 
time, the typical mechanical robustness is usually maintained, simplifying downstream 
processing as centrifugation. 
 
 
 
 
Figure I-4. Structure of the cell surface of yeast. CW Cell wall, CM cell membrane, PMP plasma 
membrane protein (From (Ding et al. 2008)). 
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Figure I-5. Structure of the plasma membrane. 
 
Because mammalian cells do not have a cell wall, they are more susceptible to mechanical 
stress. The permeabilization further weakens the cell membrane (Fig. I-5). For this reason, 
permeabilized mammalian cells can only be centrifuged at relatively low speeds (Niklas et 
al. 2011). In contrast to bacterial and yeast cells permeabilization of mammalian cell 
membranes normally leads to the release of a large fraction or even all cytosolic proteins into 
the medium because there is no cell wall retaining these proteins (Cook et al. 1983; Niklas et 
al. 2011). When treating mammalian cells with crosslinking reagents prior to 
permeabilization, this loss can be avoided (Aragon et al. 1980). It has been shown that the 
cell membrane of Chinese hamster ovary (CHO) cells can be selectively permeabilized while 
leaving the mitochondrial membrane intact, such as by using digitonin (Niklas et al. 2011). 
Full permeabilization is obtained using other surfactants, e.g. Triton X-100, and other 
permeabilization conditions (Niklas et al. 2011). 
 
2.2 Permeabilization methods/agents 
 
It needs to be mentioned in advance that there is no generally optimal permeabilization 
method. It depends on the organism to be permeabilized and has to be tailored to meet the 
requirements of the following processes. Normally, it is not possible to predict which method 
is suitable for a certain organism. Even when working with different strains of the same 
organism, very different approaches may be necessary for successful permeabilization 
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(Cánovas et al. 2005; Krauser et al. 2012; Zhang et al. 2006a; Zhang et al. 2006b; Zhang et al. 
2009). So far, optimal conditions have to be identified experimentally by a trial-and-error 
procedure. However, as our knowledge of membrane processes on molecular scale keeps 
growing (Klymchenko and Kreder 2014) it might be possible to predict suitable 
permeabilization conditions in the future. 
Organic solvents 
Toluene is the most commonly used solvent for cell permeabilization. Studies on its effect on 
E. coli were carried out as early as 1965 (Daines et al. 2004). During permeabilization, cells 
released 25% of total cell protein into the surrounding medium. In the presence of Mg
2+
 only 
very little cell material was released. Even nucleotides remained within the cells. The 
lipopolysaccharide layer of the outer membrane is bound to the membrane by divalent 
cations. Their presence therefore protects the cell from nonpolar compounds (such as toluene) 
(Silhavy et al. 2010). It was shown by electron microscopy that toluene mainly damages the 
cell membrane, whereas the outer membrane was left intact. More recent publications point 
out that permeabilization with solvents is more harmful to some cells and less reproducible 
than the use of surfactants (Daines et al. 2004). On the other hand, E. coli and two Bacillus 
strains were successfully permeabilized using a combination of ethylenediaminetetraacetic 
acid (EDTA) and low toluene concentrations in 2009 (Zhang et al. 2006b; Zhang et al. 2009). 
Furthermore, yeast cells could be permeabilized by treatment with mixtures of chloroform, 
ethanol, and toluene (Datsenko 2000). 
Surfactants 
Currently, surfactants are the most commonly used permeabilizing agents. There are three 
general mechanisms by which surfactants can interfere with the cellular membrane. If 
applied in concentrations above their critical micellar concentration, they can form micelles 
consisting of a mix of membrane compounds and surfactant molecules. The cationic part of 
surfactants such as cetyltrimethylammonium bromide (CTAB) can interact with the 
negatively charged membrane, which disturbs its structure and causes permeability (Kaur et 
al. 2009). The nonpolar part, which is of course found in all surfactants, can integrate into the 
membrane due to its high affinity to the lipids nonpolar tail, disturbing its transversal 
organization. In practice, it is to be expected that permeabilization occurs due to a 
combination of these effects (Abraham and Bhat 2008; Jamur and Oliver 2010; Zaragoza et 
al. 2009).  
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Most proteins contain polar and nonpolar parts due to the respective amino-acid side-chains. 
This makes them susceptible to the binding of surfactants, which can lead to conformational 
changes and ultimately denaturation of the protein if the surfactant concentration is 
sufficiently high (Tandon and Horowitz 1987; Weber and Kuter 1971; Womack et al. 1983). 
The most notable example of the affinity of surfactants for proteins is sodium dodecyl sulfate 
(SDS) polyacrylamide gel electrophoresis, in which proteins are ‘‘covered’’ with the 
surfactant SDS) (Weber and Kuter 1971). When permeabilized with the nonionic surfactant 
Triton X-100, Yarrowia lipolytica released only very small amounts of protein. Electron 
microscopy confirmed that permeabilization with this surfactant is a mild process (Galabova 
et al. 1996). In 2011, Niklas et al. permeabilized the cell membrane and the mitochondrial 
membrane of CHO cells with Triton X-100, whereas treatment with digitonin (a saponin) 
selectively permeabilized the cell membrane while leaving the mitochondria intact (Fiskum 
et al. 1980; Niklas et al. 2011). Digitonin does not primarily act as a surfactant but binds to 
cholesterol (Sperry and Webb 1950), which is more abundant in the cell membrane than in 
the mitochondrial membrane (Colbeau et al. 1971). The previously mentioned surfactant 
CTAB is the most commonly used permeabilizing agent harboring a permanent positive 
charge. By its strong binding to lipids and phospholipids, it induces pore formation in 
cellular membranes (Cheng et al. 2007). When permeabilizing S. cerevisiae with CTAB, 
Gowda proved that permeabilization was dependent on the ratio of amount of surfactant to 
cells rather than surfactant concentration in the medium (Gowda et al. 1991). The Upadhyas 
group treated yeast cells with 1% glutaraldehyde prior to permeabilization with CTAB. In 
this way, protein leakage was greatly reduced and the cells could be reused 20 times as 
catalyst in the oxidation of D-phenylalanine to phenylpyruvate (Upadhya et al. 2000). An 
overview of surfactants used for permeabilization is given in Table I-1. 
Chelating agents 
The structural stability of membranes and most cell wall structures is based on electrostatic 
interactions and van der Waals forces. Divalent cations counterbalance the negative charges 
of phosphate groups, allowing these groups to stay densely packed. Furthermore, the 
lipopolysaccharide layer of Gram-negative bacteria is attached to the outer membrane by 
calcium and magnesium ions. Chelating agents, such as EDTA (McCord and Day 1978) form 
stable complexes with these cations, separating them from the cells. This process disturbs the 
cell membrane and causes the release of lipopolysaccharides (Vaara 1992). It has been shown 
that cells of B. pumilus, B. subtilis, and E. coli permeabilized with EDTA and low (7% v/v) 
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toluene concentration are effective catalysts for NADPH regeneration and asymmetric 
reductions (Zhang et al. 2006b). These cells showed high stability and could be reused three 
times as catalyst in 68-h batch reactions (Zhang et al. 2006b; Zhang et al. 2009). G. oxidans 
and R. eutropha were permeabilized with EDTA and toluene (2% v/v) and then used as 
catalyst in a reduction reaction using hydrogen as reductant (Rundback et al. 2012). 
Combining EDTA treatment with low toluene concentrations seems to permeabilize cells 
effectively without the disruptive effect caused by permeabilization with toluene alone (at 
high concentrations). The permeabilization of P. putida with EDTA was optimized with 
regard to EDTA concentration, temperature, treatment time, and pH with the support of a 
statistical experimental design with the goal of conversion of limonene (Malik et al. 2012).  
Peptides and Proteins 
Eukaryotes synthesize numerous peptides and small proteins with antimicrobial activity. 
Many of these compounds act by permeabilizing microbial, fungal, and viral cellular 
envelopes (Hill et al. 1991; Lehrer et al. 1989). Defensins are small, rigid (internal disulfide 
bonds), and positively charged (high arginine content) peptides. Due to their positive charge, 
they can integrate into the negatively charged membranes and associate to form multimeric 
pores (Lichtenstein 1991; van Kan et al. 2002; White et al. 1995). It should be mentioned that 
polyethylenimine, a polymer that is positively charged under physiological conditions, 
exhibits a similar effect (Cánovas et al. 2005). Beside the pore-forming activity, cationic 
peptides can displace calcium and magnesium from the outer membrane, thus destabilizing 
this region. Different mechanisms of action have been discussed and attempts of establishing 
structure–activity relationships have been described (Powers and Hancock 2003). The protein 
psoriasin has been proven to kill E. coli at neutral pH without damaging its membrane, 
whereas at low pH it acts against B. megaterium by membrane permeabilization (Michalek et 
al. 2009). In 2009, the channel-forming peptide alamethicin was used to permeabilize A. 
thaliana and tobacco suspension cells to study callose synthase activity. In these experiments, 
it was superior to surfactant digitonin, which showed an inhibitory effect on the involved 
enzymes (Aidemark et al. 2009). 
Other permeabilizing agents  
Ionophores are compounds that can carry ions through biological membranes. Nigericin was 
used to permeabilize HeLa cells to release metabolites and small proteins without interfering 
with protein synthesis (Alonso and Carrasco 1982). When desiring to remove soluble proteins 
Introduction 
 
 
20 
from the cytoplasm, the cell membrane can be partly removed by enzymatic digestion. This 
approach has been applied to different yeast strains (Ferrer et al. 1996; Kearsey et al. 2005). 
Table I-1. Permeabilizing agents. (OS) organic solvent, (D) surfactant, (P) peptide, (C) chelating 
agent. 
notable examples (methods/agents) structures 
mechanism of 
permeabilization/notes 
Toluene (OS) 
 (Cánovas et al. 2005; Flores et al. 1994; 
Jackson and Demoss 1965; Martin et al. 
2011; Rundback et al. 2012; Thedei et al. 
2008; Zhang et al. 2009) 
 
-disrupt the cell membrane 
-often combined with EDTA as the 
amount of damage done to 
membranes is strongly dependent on 
divalent cation concentrations 
Ethanol(OS) 
 (Cánovas et al. 2005; De Groeve et al. 
2009; Jamur and Oliver 2010; Tokuda 
and Matsuyama 2004; Upadhya et al. 
2000) 
 
Chloroform (OS) 
 (Flores et al. 1994) 
CHCl3 
Triton X-100 (D) 
 (Bernal et al. 2007; Cánovas et al. 2005; 
Jamur and Oliver 2010; Martin et al. 
2011; Miozzari et al. 1978; Niklas et al. 
2011; Yuan and Heinzle 2009) 
 
n=8-9 
-nonionic surfactant 
-partly dissolves membranes un-
specifically 
CTAB (D) 
 (Cheng et al. 2006; Foulstone and 
Reading 1982; Kaur et al. 2009; Silhavy 
et al. 2010; Upadhya et al. 2000)  
-cationic surfactant 
-partly dissolves membranes un-
specifically 
Tween 80 (D) 
 (Aidemark et al. 2009; Bernal et al. 
2007; Bogman et al. 2003; Cánovas et al. 
2005; Elling 1996; Powers and Hancock 
2003; Shen et al. 2002; Tokuda and 
Matsuyama 2004) 
 
-nonionic branched polyether 
-partly dissolves membranes un-
specifically 
Digitonin (D) 
 (Aragon et al. 1980; Cook et al. 1983; 
Fiskum et al. 1980; Niklas et al. 2011) 
 
-steroid glycoside 
-selectively permeabilizes 
membranes with high cholesterol 
content 
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notable examples (methods/agents) structures 
mechanism of 
permeabilization/notes 
EDTA (C) (Malik et al. 2012; McCord 
and Day 1978; Rundback et al. 2012; 
Rutter and Denton 1992; Ryan and 
Parulekar 1991; Upadhya et al. 2000; 
Vaara 1992; Zhang et al. 2006b; Zhang 
et al. 2009) 
 
-complexation and thus removal of 
divalent cations required for 
membrane stability 
Alamethicin (P) (Aidemark et al. 2009; 
Bonnafous et al. 1982; Johansson et al. 
2004) 
 
channel forming 
 
Physical methods 
Electric pulse methods 
 
Electroporation is a well-established method for introducing foreign DNA into organisms 
(Becker and Guarente 1991; Dower et al. 1988; Fromm et al. 1987). However, it can also be 
used to permeabilize cells for the enhancement of their catalytic properties. A general 
advantage of the electropermeabilization compared to the previously described chemical 
methods is that no foreign substances, such as surfactants or solvents that can interfere with 
enzymes, need to be added (Tryfona and Bustard 2006). Because the conductivity of lipid 
bilayers is very low, the application of an external electric field creates a potential difference 
across the membrane (Escoffre et al. 2007). This causes alterations within the membrane, 
disturbing its structure and leading to pore formation. An additional nanoscale fragmentation 
of the membrane has been proven (Pliquett et al. 2007). In 2008 Tryfona et al. reported the 
enhancement of amino acid release by C. glutamicum after electropermeabilization 
demonstrating the potential of this approach for production purposes (Tryfona and Bustard 
2008).  
Other physical methods 
An osmotic shock causes cells to change their size rapidly thus causing stress to the cellular 
membranes and potentially leading to permeabilization. This approach has been used to 
permeabilize yeast (Crotti et al. 2001) and fungi (Sestak and Farkas 2001) for enzymatic 
activity studies in situ. As mammalian cell envelopes do not contain a peptidoglycan layer 
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protecting them from osmotic lysis the osmotic shock method is not suitable to permeabilize 
these cells (Bernal et al. 2007; Cánovas et al. 2005). Freezing and thawing of cells has been 
studied as a method for cell permeabilization as well. It is generally combined with the 
application of surfactants (Bernal et al. 2007; Cánovas et al. 2005; Miozzari et al. 1978)  
3. Enzymatic synthesis of complex molecules 
Although in vitro biotransformation of all kinds of simple and complex molecules has reached 
a very high standard with numerous applications (Bornscheuer et al. 2012; Liese et al. 2000), 
the biosynthesis of complex molecules from simple and inexpensive precursors is still 
dominated by in vivo systems (i.e. whole living cells in fermentation processes). Although the 
main focus in in vitro synthesis is the characteristics of the enzyme applied (Bornscheuer et 
al. 2012), in vivo production focuses on a whole network or on organism characteristics. Up-
to-date design of synthesis using whole metabolic networks starts with stoichiometry-based 
methods, usually ﬂux balance analysis (Becker et al. 2011; Curran et al. 2012; Kroemer et al. 
2006; Neuner and Heinzle 2011). Similarly, the design of more complex networks of cell 
extracts (Bujara and Panke 2012) or permeabilized cells will start out from information that is 
readily available from public databases. The operability of a path or network is additionally 
dependent on favourable thermodynamics, which is increasingly accessible via databases, and 
even more with the development of methods for molecular energy calculations (e.g. using 
group contribution methods (Bujara and Panke 2012; Soh et al. 2012) A full quantitative 
description for a fully model-based design would also include kinetics, which are much more 
difficult to describe. 
3.1 Enzymatic reactions 
Living organisms rely on metabolic networks with amazingly efficient synthetic routes to 
provide essential intermediates and building blocks for cellular polymers but also for other 
low molecular weight compounds—so-called secondary metabolites (Yuryev and Liese 
2010). Enzymes catalyzing these reactions are highly conserved in their three-dimensional 
structure and chemical function despite the genomic diversity among organisms (Weinig et 
al. 2003). Thousands of biologically synthesized molecules that are already known and those 
that are not yet discovered give an image of the powerful synthetic machinery that cells can 
rely on. For conducting chemical reactions, enzymes often include cofactors (coenzymes or 
cosubstrates as well as prosthetic groups). 
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When using permeabilized cells, it is important to distinguish carefully between cosubstrates 
that are dissolved in cellular compartments, such as cytosol, and prosthetic groups that are 
integral parts of enzymes. Permeabilization will allow cosubstrates to diffuse freely out of the 
cells, whereas prosthetic groups would remain within the cells attached to their protein hosts. 
As a consequence, cosubstrates can be added in a targeted way to a biosynthetic network 
captured within the permeabilized cell membrane and are thus a design variable. Cofactors are 
necessary to provide energy, redox equivalents and carbon-units and are evolutionary 
preserved (Table I-2). In some cases, enzymes can even operate in thermodynamically 
unfavorable direction provided resulting products are removed by following exergonic 
processes (Wessjohann et al. 2012). Water plays an essential role in all naturally occurring 
enzymatic reactions. By entropy effects and acid/base catalysis as well as regulating the 
tertiary structure of enzyme folding, it influences binding of substrates and actual catalytic 
activity (Branco et al. 2009). Non-aqueous solvents do not only change the solubility of 
substrates, products and intermediates but also have a strong impact on the structure of 
enzymes and therefore their catalytic activity (Trodler and Pleiss 2008). The application of 
non-aqueous solvents in multi-enzyme biocatalysis seems more difficult because of the 
expected influences on individual enzymes of such a biocatalytic network. Enzymes do 
usually not only convert the major substrates listed in databases but may act on a whole 
spectrum of compounds; for example, many proteases can also act as esterases (a well-
known textbook example). This complicates the design of more complex networks, but it also 
opens up lots of opportunities to create variations of metabolites, potentially leading to new 
pharmaceuticals or to precursors for further substrate analogues, whereas others have to be 
tailored (Struck et al. 2012; Thirlway et al. 2012). 
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Table I-2. Cofactors in enzyme reactions. 
Cofactor Group transfer Species 
3'-Phosphoadenosine-5'-
phosphosulfate 
Sulfate group Bacteria, archaea and eukaryotes 
Adenosine triphosphate Phosphate group Bacteria, archaea and eukaryotes 
Ascorbic acid Electrons Bacteria, archaea and eukaryotes 
Biotin CO2 Bacteria, archaea and eukaryotes 
Cobalamine Hydrogen, alkyl groups Bacteria, archaea and eukaryotes 
Coenzyme A 
Acetyl group and other acyl 
groups 
Bacteria, archaea and eukaryotes 
Coenzyme B Electrons Methanogens 
Coenzyme F420 Electrons Methanogens and some bacteria 
Coenzyme M Methyl group Methanogens 
Coenzyme Q Electrons Bacteria, archaea and eukaryotes 
Cytidine triphosphate 
Diacylglycerols and lipid head 
groups 
Bacteria, archaea and eukaryotes 
Flavin adenine dinucleotide Electrons Bacteria, archaea and eukaryotes 
Flavin mononucleotide Electrons Bacteria, archaea and eukaryotes 
Glutathione Electrons 
Some bacteria and most 
eukaryotes 
Heme Electrons Bacteria, archaea and eukaryotes 
Lipoamide Electrons, acyl groups Bacteria, archaea and eukaryotes 
Menaquinone Carbonyl group and electrons Bacteria, archaea and eukaryotes 
Methanofuran Formyl group Methanogens 
Methylcobalamin Acyl groups Bacteria, archaea and eukaryotes 
Molybdopterin Oxygen atoms Bacteria, archaea and eukaryotes 
NAD+ and NADP+ Electrons Bacteria, archaea and eukaryotes 
Nucleotide sugars Monosaccharides Bacteria, archaea and eukaryotes 
Pyridoxal phosphate Amino and carboxyl groups Bacteria, archaea and eukaryotes 
Pyrroloquinoline quinone Electrons Bacteria 
S-Adenosyl methionine Methyl group Bacteria, archaea and eukaryotes 
Tetrahydrobiopterine Oxygen atom and electrons Bacteria, archaea and eukaryotes 
Tetrahydrofolic acid 
Methyl, formyl, methylene 
and formimino groups 
Bacteria, archaea and eukaryotes 
Tetrahydromethanopterin Methyl group Methanogens 
Thiamine pyrophosphate] 2-carbon groups, α cleavage Bacteria, archaea and eukaryotes 
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3.2 Enzyme kinetics 
Although the kinetics of biosynthetic networks generally follows the same principle as that of 
isolated enzymes, some peculiarities have to be considered because of macromolecular 
crowding (Minton 2006). One known but quantitatively little-characterized effect is 
channeling—that is, the direct transfer of substrates to the following enzyme in a cascade 
reaction (Zhang 2011). 
Biocatalytic network kinetics can be modeled in various ways. In the most-simple approach, 
one attempts to identify the limiting catalytic step and use the kinetics of this step to describe 
the whole process. This is adequate as long as this step is remaining the limiting one. This 
may change during optimization. In a second alternative approach, full kinetics of all relevant 
reaction steps are applied. This requires, however, the elaboration of the kinetics of all 
individual enzymes and it will only be valid if no secondary effects as metabolite channeling 
occur. Wilson et al. have recently characterized the kinetics of a dimodular nonribosomal 
peptide synthetase (Wilson et al. 2013). A new powerful method for larger scale kinetic 
analysis that seems applicable to permeabilized cells as well has been presented recently 
(Link et al. 2013). Network oriented approaches use power-law kinetics, e.g. for secondary 
metabolism in plants (Heinzle et al. 2007), or lin-log kinetics (Wu et al. 2004), that do not 
require a full kinetic analysis of each single enzyme but an evaluation of the whole network of 
interest. 
It is important to note that in permeabilized cells, it is possible to add desired substrates and 
omit undesired ones in a directed manner, thus preventing activity of undesired reactions 
(Krauser et al. 2012; Yuan and Heinzle 2009). However, all enzymes present remain ready 
but have to be considered sleeping unless their corresponding substrates are present. In more 
complex cases, it will usually not be avoidable to create intermediates that can react with 
present substrates, intermediates, or products. In this case, it is generally possible to delete the 
genes coding for undesired enzymes or to inhibit them by selective inhibitors. Because most 
enzyme-catalyzed conversions are equilibrium reactions, excess supply of reactants can push 
them in the desired direction. This extends the operability of bioconversions while the 
working range of native enzymes has to be respected (Broadwater et al. 2005). 
Enzymes will usually be inactivated, in a nonphysiological environment. An advantage of 
permeabilized cells with respect to catalytic activity is the stabilizing effect of the protective 
environment inside the cell. Enzyme activity can be retained for several days in a suitable 
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buffer media (Yuan and Heinzle 2009). Even multiple uses of permeabilized cells in some 
cases did not affect the activity of the enzymes significantly (Felix 1982). Enzyme stability 
very much depends on the nature of the enzyme and the environment to which it is exposed. 
Often, storage stability is significantly different from operational stability, such as for 
oxidases (Treitz et al. 2001). This is in contrast to isolated enzymes, which are exposed to 
damaging influences and often have to be modified genetically to increase their stability 
(Wohlgemuth 2007).  
3.3 Synthesis of complex metabolites 
Natural products represent powerful lead structures for new pharmaceutically active agents 
(Clardy and Walsh 2004). Methods for discovering and producing new secondary metabolites 
are increasingly powerful (Bode and Muller 2005; Wu et al. 2012). There is an increasing 
interest to also produce modifications of natural metabolites (Walsh et al. 2013; Wong and 
Khosla 2012) that would certainly be stimulated if cell extracts or permeabilized cells could 
carry out such complex syntheses. 
Some biosynthetic enzymes form megasynthetases by aggregation and posttranslational 
modification and are mostly coded by contiguous operons on the genome. Those clusters 
build up biosynthetic machineries for larger, complex molecules, such as secondary 
metabolites (Kim et al. 1994; Pickens and Tang 2009; Pulsawat et al. 2007; Schultz et al. 
2008; Tang et al. 2004). So far, it is hardly possible to isolate such complexes in an active 
form, and rebuilding them in vitro only works for smaller, simple aggregates (Cryle and 
Schlichting 2008; Schlichting and Cryle 2009). However, substrate channeling in enzyme 
clusters enables effective bioconversion, limiting side reactions (Monti et al. 2009). 
Intermediates towards the product are passed among the subunits of a megasynthetase and 
shielded from the surrounding environment, such as the cytosol. This allows high reaction 
rates and improves selectivity. Scheme I-1 shows the biosynthesis of the secondary metabolite 
luminmide A in Photorhabdus luminescens within the megasynthetase complex (Fu et al. 
2012). 
Because most of the pharmaceutical bioactives that are produced biotechnologically target 
microbial growth, production of such compounds in microorganisms is limited. Resistance 
concerning the synthesized product and secretion from the cellular plasma is highly 
demanded to preserve the fitness of the producing strain. This causes a significant loss in 
efficiency (Stevens et al. 2010). Although living organisms have to be prepared for the stress 
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resulting from toxic products, using them in a permeabilized state can reduce this problem if 
toxic effects do not directly involve the actual biosynthesis but only other essential functions, 
such as respiration. Cells can be easily grown in their preferred conditions. Triggered 
expression of corresponding synthesis genes in the late, stationary growth phase does not 
affect replication very much. In the case of megasynthetase clusters, controlled induction is 
even more advantageous because they are naturally expressed only at very low copy 
numbers. High expression rates may produce dysfunctional aggregates, such as inclusion 
bodies. On the other hand, when using permeabilized cells, it is easy to set cell 
concentrations to a desired value (Krauser  e t  a l .  201 2) . In that way, it is possible to 
reach catalytic activity that would not be possible by regular growth, thus enhancing the 
volume-related synthesis rate compared to in vivo production during fermentation. 
 
 
Scheme I-1. Formation of Luminmide A. The L-enantiomers of phenylalanine, valine and 
leucine are direct precursors and ATP serves as cofactor. Domains: adenylation A, 
thiolation T, condensation C, combined epimerization/condensation E/C, thioesterase Te 
(Fu et al. 2012). 
 
The use of such large enzyme clusters for synthetic applications in permeabilized cells has 
diverse advantages. Accessing synthesis clusters via permeabilized cell membranes is not 
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known to harm the native assembly of subunits (Niklas et al. 2011). The surfactant itself 
might affect the complex’s structure. The synthetic machinery can thus be addressed in situ 
so that biosynthesis can occur in an environment that can be easily controlled and 
influenced—provided that the corresponding route and cofactors are known and available. 
Because many secondary metabolite synthetase clusters are spread all over microbial 
genomes, their identification is considerably more difficult. Only very few have been 
investigated in more detail concerning their mechanism and kinetics (Wilson et al. 2013). 
Resolving reaction mechanisms and intermediates from known starting monomers to the 
final compound is very laborious. Research will not only provide some insight into how the 
biosynthetic toolbox evolved but may also inspire scientists to copy and modify enzyme 
complexes by known or new engineering tools. Table III-3 lists major secondary metabolite 
classes and their link to primary metabolism. 
In nature, megasynthetases can combine several subunits synthesizing hybrids of those 
classes, such as for alkaloid synthesis in plants (Weissman and Muller 2008). Research in this 
area underwent astonishing and promising progress in the last decade. The growing number 
of known biosynthetic paths enlarges the range of potential synthetic applications as well as 
the understanding of genomic coding across species (Cheng et al. 2007; Findrik and Vasic-
Racki 2009). Extensive knowledge of genomes increasingly allows the identification and 
later activation of silent gene clusters (Ochi and Hosaka 2013). Engineering of secondary 
metabolite production in streptomycetes (Medema et al. 2011) and myxobacteria (Wenzel 
and Muller 2009) is increasingly providing new opportunities for the application of 
permeabilized cells. The previously mentioned synthesis gene cluster of Luminmide of P. 
luminescens was transferred into E. coli Nissle using direct cloning with full length RecE 
technique (Fu et al. 2012; Ongley et al. 2013).  
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Table III-3. Classes of secondary metabolites, building blocks, and common examples. 
 
Such efficient cloning tools enable biotechnologists to use specific synthetic skills of hard-
to-handle organisms in robust production organisms, such as E. coli. There is a great 
interest in creating natural and modified versions of complex low molecular weight 
compounds, such as polyketides or nonribosomal peptides and mixtures thereof (Walsh et 
al. 2013; Wong and Khosla 2012). 
Another very fast growing field is the in vitro reconstruction of such synthetic pathways. 
Enzymes are brought together in one pot to perform multistep syntheses, either in 
microreactors (i.e. nanocontainers) or arranged on preset scaffolds (i.e. attached to a DNA 
linker) (Akai et al. 2010; Caiazzo et al. 2009; Dudley et al. 2015; Fowler and Koffas 2009; 
Moses et al. 2013; Santacoloma et al. 2011; Tanner et al. 2011). 
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3.4 Enzymes beyond nature 
A very interesting field in engineering bioconversions is tailoring enzymes for specific 
tasks. The fast-growing community for enzyme engineering is aiming to manipulate 
enzyme properties for applications in chemical processes. Mainly, the resistance against 
organic solvents and high temperatures as well as stability and the ability to immobilize 
them attached to supports are driving the development of enzyme engineering (Thirlway et 
al. 2012). In silico designed enzymes carrying out thus far unknown reactions are targets of 
research as well (Richter et al. 2011; Siegel et al. 2010). Increasing knowledge of 
enzyme-substrate interaction at the transition state enables scientists to simulate reactions 
that cannot be carried out by any known natural enzyme, thus extending the space 
reachable via biosynthesis. A very interesting biosynthetic concept was recently described 
by Ye et al., expressing pathways from thermophilic organisms in a mesophilic one with 
subsequent inactivation of mesophilic activities at higher temperatures (Ye et al. 2013; Ye 
et al. 2012). 
Modern genetic tools enable tailoring sequences of native enzymes, thus modifying their 
activity profiles; for example, one can extend their substrate spectrum, switch cofactor 
requirements, and enhance thermostability and solvent stability. This is done either by 
using evolutionary methods supported by large screening platforms or applying rational 
design methods (Nestl et al. 2011). Screening methods are becoming more automated and 
allow efficient high-throughput analysis of large libraries of mutants. Computer models 
have become increasingly powerful and can predict the relationship between the structure 
of an enzyme and its function. Enzyme engineering is increasingly introduced into the 
engineering of whole secondary metabolite pathways (Bar-Even and Salah Tawfik 
2013). 
Not every enzyme needs to be engineered to carry out unnatural reactions. In some cases, 
enzymes convert derivatives of their main substrate like the original (Walsh et al. 2013; 
Wessjohann et al. 2012). Living cells, with their distinct metabolism, limit the supply of 
unnatural substrates; however, with permeabilized cells, it is possible to expose enzymes 
with unnatural reagents, thus exploring pathways that do not occur in nature. This might 
permit the use of existing biosynthetic pathways for synthesizing artificial analogs of 
secondary metabolites via a supply of unnatural substrates. 
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4. Aims and scope of this thesis 
The aim of this work was to elucidate the potential of permeabilized cells for synthesis 
applications. Prior to metabolite synthesis, suitable conditions for cell permeabilization 
needed to be determined. Here a trial-and-error based approach was applied, as the prediction 
of appropriate permeabilization procedures for a given strain is not possible thus far. 
Initially, two metabolites which are relatively close to the central carbon metabolism were 
targeted. The first project focused on synthesizing nucleotide sugar UDP-glucose using E. 
coli. Here all relevant enzymes were already present in the wild type strain initially used. To 
gather information on the factors which influence the permeabilization process the effects of 
temperature, pH, detergent concentration and cell density on cell permeabilization were 
determined. Then the yield of nucleotide sugar synthesis with the applied permeabilized cell 
catalyst was optimized and cofactor regeneration was established to determine the potential of 
the developed catalyst. In the second project a recombinant S. pombe strain was used to 
synthesize UDP-glucuronic acid. First a permeabilization strategy was developed for this 
strain. After determination of optimal reaction conditions, UDP-glucose was quantitatively 
converted to UDP-glucuronic acid demonstrating the absence of side reactions and the 
sustainability of the process.  
In the second part the potential of permeabilized cells for the synthesis of secondary 
metabolites was studied. An E. coli strain expressing the gene cluster for the biosynthesis of 
NRP luminmide was used. To gain insight into the kinetic behavior of the enzyme complex 
cells were exposed to different substrate mixtures and apparent kinetic parameters were 
calculated. In order to elucidate enzyme promiscuity several non proteinogenic amino acids 
were added to the substrate cocktail and the resulting products were studied with LC-MS
2
.  
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II. Multistep Synthesis of UDP-Glucose 
Using Tailored, Permeabilized Cells 
of E. coli. 
 
ABSTRACT: We constructed and applied a recombinant, permeabilized E. coli strain for the 
multistep synthesis of UDP-glucose. Sucrose phosphorylase (E.C. 2.4.1.7) of Leuconostoc 
mesenteroides was over expressed and the pgm gene encoding for phosphoglucomutase (E.C. 
5.4.2.2) was deleted in E.coli to yield the E.coli JW 0675-1 SP strain. The cells were 
permeabilized with the detergent Triton X-100 at 0.05% v/v. The synthesis of UDP-glucose 
with permeabilized cells was then optimized with regard to pH, cell density during the 
synthesis and growth phase during cell harvest, metal co-factor, other media components and 
temperature. In one configuration sucrose, phosphate, UMP and ATP were used as substrates. 
At pH 7.8, 27 mg/ml cell dry weight, cell harvest during the early stationary phase of growth 
and Mn
2+
 as cofactor a yield of 37% with respect to UMP was achieved at 33 °C. In a second 
step ATP was regenerated by feeding glucose and using only catalytic amounts of ATP and 
NAD
+
. A UDP-glucose yield of 60% with respect to UMP was obtained using this setup. 
With the same setup but without addition of external ATP the yield was 54%. 
 
 
 
 
 
 
 
 
The following chapter was published as “Multistep Synthesis of UDP-Glucose Using 
Tailored, Permeabilized Cells of E. coli.” in “Applied Biochemistry and Biotechnology” 
(Weyler and Heinzle 2015).  
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1. Introduction 
The synthesis of metabolic intermediates is of broad industrial interest (Breuer et al. 2004; 
Kuriata-Adamusiak et al. 2012). Multi-enzyme biocatalysis is a promising alternative to 
multi-step organic synthesis or production by living cells (Chae et al. 2010; Eikmanns et al. 
1993). UDP-glucose is a major reactive intermediate in carbohydrate metabolism, particularly 
for the biosynthesis of oligomers and polymers of glucose and complex oligomeric 
carbohydrates. As a key intermediate for glycosylation reactions it acts as a glucose donor and 
is an intermediate in galactose metabolism (Elling and Bülter 1999). UDP-glucose was 
produced using freeze dried cells of Candida saitoana (Ko et al. 1996) as catalyst. 
Cell permeabilization has been used as a method for the study of metabolic processes for 50 
years (Felix 1982; Heinzle et al. 2013; Kondo et al. 2000; Niklas et al. 2011). When cells are 
treated with mild permeabilizing agents (i.e. detergents) their microscopic structure remains 
intact but the cell membrane becomes permeable to small molecules. After washing away 
these molecules, only macromolecules like enzymes stay within the cell and become 
accessible for any low molecular weight compound that is added to a cell suspension. These 
cells can then be used as multi-enzyme catalyst (Heinzle et al. 2013; Krauser et al. 2012). 
We used permeabilized E. coli for the multi-enzyme synthesis of UDP-glucose under defined 
conditions. We overexpressed sucrose phosphorylase (SPase) from Leuconostoc 
mesenteroides (Goedl et al. 2007) in a strain lacking phosphoglucomutase. Using this strain, 
we could directly produce UDP-glucose using sucrose, UMP and ATP. ATP could also be 
regenerated via glycolysis after feeding glucose and adding catalytic amounts of NAD
+
. 
Addition of small amounts of ATP further stimulated UDP-glucose production. 
2. Results & discussion 
2.1 Cell permeabilization 
The activity of malate dehydrogenase (MDH) (Yuan and Heinzle 2009) was used to monitor 
the progress of permeabilization and optimize cell density, Triton X-100 concentration, 
temperature and incubation time. At a dry cell density of 13.5 g/l, MDH activity increased 
until a Triton X-100 concentration of 0.05% v/v and remained constant at higher detergent 
concentrations (Fig. II-1). The activity of fully permeabilized cells was identical (±2%) to the 
activity of cell extract without any detergent.  
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MDH activity increased linearly with cell density in the range from 1.69 to 13.5 g/l CDW 
(Fig. II-2). At higher densities it increased less, potentially caused by insufficient availability 
of Triton X-100. It is likely that a combination of higher cell density and higher Triton 
concentration would be effective as well but might potentially cause enzyme inactivation.  
The effects of permeabilization temperature (0, 10, 20, 30, 37 and 45 °C) and incubation time 
with Triton X-100 (1, 2, 5, 10, 20, 30 min) were also examined. Temperature effects on 
permeabilization were studied applying an incubation time of 10 minutes. The effect of 
different incubation times was investigated at 20 °C. In all cases except 45 °C the MDH 
activity was identically high (data not shown). A comparison of the protein contents of          
 
Figure II-1. Rates in malate dehydrogenase (MDH) assay at varying Triton X-100 concentrations. 
Cell density was 13.5 mg CDW / ml. 
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Figure II-2. Malate dehydrogenase (MDH) activity at varying cell density. Triton X-100 
concentration was always 0.05% v/v. Only the first four data points were taken into consideration 
for the linear regression. 
cell lysate and of samples taken after 2 hours of reaction revealed that less than 2% of cellular 
protein was released into the supernatant. Overall, the permeabilization process is very robust 
and efficient. 
2.2 Synthesis of UDP-glucose 
Initial studies were carried out with permeabilized E. coli K-12 cells. With UMP (10 mM), 
ATP (20 mM) and G1P (10 mM) as substrates the yield did not exceed 15% (1.5 mM) with 
respect to UMP. In WT E. coli G1P can be isomerized to G6P by phosphoglucomutase (Pgm). 
To prevent related loss of G1P via G6P and glycolytic reactions, E. coli JW 0675-1 where the 
pgm gene coding for phosphoglucomutase (E.C. 5.4.2.2) was deleted was used (Baba et al. 
2006). With this strain a yield of 30% with respect to applied UMP was reached under 
optimized conditions after adding stoichiometric amounts of G1P and ATP.  
The pQE 30-LmSPase plasmid carrying the SPase gene from Leuconostoc mesenteroides was 
transformed into E. coli JW 0675-1 to yield the strain E. coli JW 0675-1 SP. Using this strain 
G1P was supplied via phosphorolysis of less expensive sucrose by sucrose phosphorylase 
(SPase) (Goedl et al. 2007). The resulting reaction-network is shown in Scheme II-1.  
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Scheme II-1. Reaction network of UDP-glucose biosynthesis in E.coli JW 0675-1 SP.  
Superscript letter a indicates compounds supplied in catalytic concentrations. Superscript 
letter b indicates compounds supplied in excess compared to UMP. 
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With this strain the synthesis worked best at 33 °C, pH 7.8, a cell density of 27 g/l, 5 mM 
Mn
2+
 as metal cofactor, a phosphate concentration of 5 mM and a sucrose concentration of 50 
mM. Under these conditions the maximum yield was 37%. Since no NADP
+
 was supplied, 
reactions of the oxidative branch of the PP-pathway are not possible limiting the formation of 
byproducts. 
 
Figure II-3. Time course of UDP-glucose formation under optimized conditions. Reaction mixture: 
Open triangles: MnSO4 7 mM, NaH2PO4 5 mM, sucrose 50 mM, UMP 10 mM and ATP 20 mM. 
Full circles: MgSO4 7 mM, NaH2PO4 5 mM + 42 mM added after 0, 27, 92 and 162 min, sucrose 
50 mM, UMP 10 mM, ATP 2 mM, glucose 100 mM and NAD
+
 2 mM. Full triangles: MnSO4 7 
mM, NaH2PO4 5 mM + 42 mM added after 0, 30, 90 and 150 min, sucrose 50 mM, UMP 10 mM, 
ATP 2 mM glucose 100 mM and NAD
+
 2 mM. Full squares: MnSO4 7 mM, NaH2PO4 5 mM + 42 
mM added after 0, 30, 90 and 150 min, sucrose 50 mM, UMP 10 mM, glucose 100 mM, NAD
+
 2 
mM and no addition of ATP. Open squares: MnSO4 7 mM, NaH2PO4 5 mM + 42 mM added after 
0, 30, 90 and 150 min, sucrose 50 mM, UMP 10 mM, glucose 100 mM, ATP 2 mM and no addition 
of NAD
+
. 
Further optimization of the synthesis was achieved by replacing the previously used 
stoichiometric amounts of ATP with catalytic concentrations combined with a fermentation 
Multistep Synthesis of UDP-Glucose Using Tailored, Permeabilized Cells of E. coli. 
 
 
38 
based regeneration driven by feeding glucose for glycolytic formation of ATP. If ATP 
concentrations lower than 2 mM were used, product formation was slower (Fig. II-3, full 
squares). This might be caused by high Km values of UMPK and/or NDPK enzymes under the 
given conditions. 
Remarkably, manganese was superior to magnesium as cofactor. As reported, magnesium is 
the preferred cofactor for UMPK and SPase, whereas no detailed information was found on 
the other enzymes (Meyer et al. 2008; Vainonen et al. 2005; van den Broek et al. 2004). 
Manganese activates the enzyme UDP-sugar diphosphatase (EC 3.6.1.45) which hydrolyses 
UDP-sugars (Glaser et al. 1967). However, it seems that the UDP-sugar diphosphatase is not 
highly expressed and/or manganese does not strongly activate it under the given conditions. 
Another reason for the superior effect of manganese seems to be that magnesium activates 5'-
nucleotidase (EC 3.1.3.5) hydrolyzing UMP much more than manganese (Proudfoot et al. 
2004).  
A yield of 37% with respect to UMP was achieved when ATP was used in a stoichiometric 
amount (Figure II-3, open triangles). UDP-glucose was formed with a constant rate (0.052 
mM min
-1
) during the first 72 min. At this point UMP was exhausted (as measured by 
MALDI-TOF-MS) and UDP glucose started decreasing. 
Reactions potentially consuming/degrading UDP-glucose under the given conditions are 
hydrolysis by the UDP-sugar diphosphatase (EC 3.6.1.45), lipopolysaccharide glucosyl-
transferase II (EC 2.4.1.73) and glycogenin glucosyltransferase (EC 2.4.1.186) (Goldraij and 
Curtino 1996). Part of UMP might have been hydrolyzed by 5'-nucleotidase (EC 3.1.3.5) 
(Proudfoot et al. 2004). UTP can be consumed in the uridylylation of e.g. protein PII 
(Atkinson et al. 1994). 
When ATP was used in catalytic concentrations the initial rate of product formation remained 
unchanged but product degradation was drastically reduced. Under these conditions a yield of 
60% with respect to applied UMP was reached within 2.5 hours (Fig. II-3, full triangles). 
When glucose fermentation was applied for ATP regeneration, lactate formation was 
observed. If magnesium was added instead of manganese in this reaction setup, no product 
degradation was observed but yields did not increase beyond 39% after 20 h. When no ATP 
was added to the reaction mixture, the rate of product formation was reduced but a yield of 
54% was still obtained after 4 hours (Fig. II-3, full squares). It can be concluded that trace 
amounts of ADP and/or ATP remain bound to the cells during the washing steps. Due to 
effective ATP regeneration, these small initial amounts were sufficient to support product 
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formation. When NAD
+
 was omitted in the reaction mixture, product formation stopped after 
the initially added ATP was consumed (Fig. II-3, open squares). 
To classify production with permeabilized cells (in situ) in comparison with alternative 
approaches further experiments were carried out with strain E. coli JW 0675-1 SP. Cell lysate 
(in vitro conditions) showed comparable behavior but inferior performance (not shown). The 
maximum yield was 53% after 3.5 hours. During cultivation, UDP-glucose could not be 
detected in the culture medium even after 24 h. Therefore, in vivo production is not a valuable 
option under these cultivation conditions. 
2.3 Concluding remarks 
The permeabilization of E. coli has proven to be a simple and effective method to provide a 
multi-enzyme biocatalyst for the one-pot synthesis of UDP-glucose. Overexpression of 
heterologous SPase and deletion of pgm gene encoding for phosphoglucomutase permitted a 
direct synthesis of UDP-glucose starting from UMP with simultaneous regeneration of ATP 
and G1P. In this way a yield of 60% with respect to applied UMP was reached. The resulting 
procedure is straight forward, requiring only cell cultivation and harvest, permeabilization, 
washing and incubation for synthesis of UDP-glucose. The biocatalyst can be separated from 
the reaction mixture by centrifugation or filtration. As compared to the fermentative method 
downstream processing is facilitated due to the much smaller number of metabolites present 
in the reaction mixture. The system described also lends itself to combination with further 
enzymatic reactions. Another big advantage of the permeabilization approach is that it allows 
studying reaction pathways under defined conditions without elaborate enzyme purification 
and pathway reconstitution.  
3. Experimental section 
E.coli JW 0675-1 was obtained from the Coli Genetic Stock Center (CGSC, Yale) (Baba et al. 
2006). The expression plasmid pQE 30-LmSPase harboring the SPase gene was generously 
provided by the group of Bernd Nidetzky from TU Graz (Goedl et al. 2007). It was 
transformed into E. coli JW 0675-1 using heat shock transformation (Inoue et al. 1990) to 
yield the E. coli JW 0675-1 SP strain. Transformants were selected using LB5G agar plates 
supplied with 100 µg/ml ampicillin. All cultivations were carried out in LB5G medium (5 g/l 
glucose, 10 g/l tryptone, 5 g/l NaCl, 5 g/l yeast extract) at 37 °C and 230 rpm in baffled shake 
flasks. The growth medium for E. coli JW 0675-1 SP contained the same concentration of 
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ampicillin. Cells were harvested by centrifugation (7000×g, 10 min, 4 °C) (Biofuge stratos, 
Heraeus, Hanau, Germany). The pelletized cells were then re-suspended in Tris buffer (100 
mM Tris, 200 mM KCl, pH 7.8 with HCl) and incubated with Triton X-100 for 
permeabilization. After that permeabilized cells were washed three times with NH4HCO3 
buffer (100 mM NH4HCO3, pH 7.8 with acetic acid).  
A malate dehydrogenase (MDH - E.C. 1.1.1.40) assay was used to determine the degree of 
permeabilization. To 50 µl of cell suspension/cell free extract a mixture containing 890 µl 
Tris-HCl buffer (100 mM Tris-HCl, 200 mM KCl, pH 7.8), 10 µl MgCl2 solution (200 mM), 
10 µl NADP
+
 solution (100 mM) and 40 µl malate solution (1000 mM) was added to start the 
reaction (total volume 1 ml). UV absorption at 340 nm was measured over a period of 11 min 
to follow the formation of NADPH (Spectronic Unicam, Helios -Spectronic Analytical 
Instruments, West Yorkshire, UK). The reaction temperature was kept at 30 °C using a water 
bath.  
Glass-bead treatment was used to generate cell free extract. 500 µl of cell suspension (13.5 g/l 
CDW) were mixed with 500 µg of glass beads (<0.25 mM in diameter) in a 2 ml Eppendorf 
tube and shaken for 15 min at 30 Hz at 0-4 °C using a swing mill of type mM301 (Retsch 
GmbH, Haan, Germany). The mixture was then centrifuged at 16000g and 4 °C for 15 min 
using Biofuge Fresco (Heraeus, Germany) to separate cell debris and supernatant.  
The synthesis of UDP-glucose was carried out in 100 mM NH4HCO3 buffer. The reaction 
volume was 1 ml. All reactions were carried out in 1.5 ml Eppendorf tubes. 
For sampling 20 µl of reaction mixture were pipetted into 180 µl of cold (0 °C) NH4HCO3 
buffer (pH 7.8 adjusted with acetic acid). This mixture was centrifuged (16000g, 4 °C) for 2 
min. 180 µl of supernatant were then stored at -28 °C until analysis.  
For MALDI analysis 4 µl of sample were mixed with 8 µl of 9-aminoacridin (9 g/l in 
methanol). Samples were then analyzed with matrix assisted laser desorption ionization mass 
spectrometry (MALDI 4800 TOF/TOF Analyzer, Applied Biosystems, Darmstadt, Germany) 
in negative reflector mode. A pulsed 200 Hz Nd:YAG Laser with a wavelength of 355 nm 
was used for ionization. Laser energy was set to 3600 units.  
Quantifications were carried out using UHPLC (1290 Infinity, Agilent Technologies, 
California, USA). The LC separation was carried out isocratically at a flow rate of 0.8 ml/min 
on a Supelcosil LC-18-T, 250 x 4.6 mM column at 40 °C in 20 min. The Eluent was 100 mM 
KH2PO4 buffer, pH 5.6 with KOH. Compounds were detected at 254 nm. 
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The protein content of cell lysate and of samples taken after 2 hours of reaction was 
determined using the Bio-Rad protein assay (Bradford 1976). Cell lysate was diluted 25 fold 
and samples were diluted 5 fold prior to analysis. In both cases this corresponds to a cell 
density of 0.54 g/l CDW.  
All Chemicals were purchased from Fluka (Buchs, Switzerland), Sigma-Aldrich (Steinheim, 
Germany), or Merck (Darmstadt, Germany) and were of analytical grade. 
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III. Selective Oxidation of UDP-Glucose to 
UDP-Glucuronic Acid Using 
Permeabilized S. pombe Expressing 
Human UDP-Glucose-6-
Dehydrogenase 
 
ABSTRACT 
Objectives: Application of permeabilized cells of fission yeast Schizosaccharomyces pombe 
expressing human UDP-glucose 6-dehydrogenase (UGDH, EC 1.1.1.22) for the production of 
uridine diphosphate glucuronic acid from UDP-glucose. Results: In cell extracts no activity 
was detected. Therefore, cells were permeabilized by treatment with 0.3% v/v of the detergent 
Triton X-100. After washing away all low molecular weight metabolites, the permeabilized 
cells were directly used as whole cell biocatalyst. Substrates were 5 mM UDP-glucose and 10 
mM NAD
+
. Divalent cations were not added to the reaction medium as they promoted UDP-
glucose hydrolysis. With this reaction system 5 mM UDP-glucose were converted into 5 mM 
UDP-glucuronic acid within three hours. Conclusions: Recombinant permeabilized cells of S. 
pombe can be used to synthesize UDP-glucuronic acid with 100% yield and selectivity. 
 
 
 
 
 
 
 
 
The following chapter was accepted for publication as “Selective oxidation of UDP-glucose 
to UDP-glucuronic acid using permeabilized S. pombe expressing human UDP-glucose-6-
dehydrogenase” in Biotechnology Letters.  
Selective Oxidation of UDP-Glucose to UDP-Glucuronic Acid Using Permeabilized S. 
pombe Expressing Human UDP-Glucose-6-Dehydrogenase 
 
 
43 
1. Introduction 
Metabolic intermediates are of vast industrial interest. Since such compounds often have 
complex structures, they are hardly accessible via classical organic synthesis. UDP-glucuronic 
acid is especially interesting because its synthesis requires highly regiospecific oxidation 
reactions (Hempel 1994). UDP-glucuronic acid serves as a donor of glucuronic acid in 
detoxification processes (drug metabolism phase II) and is also an intermediate in 
polysaccharide biosynthesis (Egger et al. 2010). Recent publications highlight the demand for 
an optimized method for the synthesis of sugar nucleoside derivatives (Guo et al. 2015; 
Tanaka et al. 2012). A UDP-glucuronic acid synthesizing step using isolated enzymes was 
recently incorporated into multi-enzyme synthesis of oligosaccharides (Engels et al. 2015). 
Classic biosynthesis is done in vitro with isolated enzymes or in vivo with whole living cells. 
In our approach synthesis is done in situ with permeabilized cells. When biological cells are 
treated with suitable amounts of surfactants (e.g. detergents or solvents) the cell envelope 
becomes permeable to low molecular weight compounds while large molecules like enzymes 
stay within the cells. After washing away small molecules, these “enzyme bags” can be used 
for multi-enzyme synthesis under defined conditions. By a careful choice of substrates only a 
very limited number of reactions can proceed effectively limiting by-product formation 
(Heinzle et al. 2013; Krauser et al. 2012; Weyler and Heinzle 2015). Here we applied the in 
situ approach to the selective oxidation of UDP-glucose to UDP-glucuronic acid using 
permeabilized cells of fission yeast Schizosaccharomyces pombe containing the human UDP-
glucose 6-dehydrogenase (UGDH) as catalyst. This yeast was chosen because previous 
studies demonstrated its effectiveness in the production of drug glucuronides after 
coexpression of human UDP glucuronosyl transferases (UGTs) and UGDH (Buchheit et al. 
2011b; Dragan et al. 2010). 
2. Results 
Before in situ synthesis of UDP-glucuronic acid could be studied optimal conditions for cell 
permeabilization were determined. A glucose 6-phosphate dehydrogenase assay was used to 
determine accessibility of intracellular enzymes (Yuan and Heinzle 2009). As shown in 
Figure III-1 a Triton X-100 concentration of 0.3% v/v is best suited for the permeabilization 
of S. pombe. With this setup enzymes become fully accessible while staying within the cell 
envelope.  
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Figure III-1. G6PDH activity in permeabilized S. pombe cells. 950 µl of assay solution were added 
to 50 µl of cell suspension or cell free extract to initiate the reaction. Final concentrations were: 
MgSO4 5 mM, NAD
+
 1 mM, glucose 6-phosphate (G6P) 10 mM, NH4HCO3 50 mM and 0.6 g 
permeabilized cells l
-1
. Reaction pH was 7.8. UV absorption at 340 nm was measured to follow the 
formation of NADH (Spectronic Unicam, Helios α-Spectronic Analytical Instruments). Error bars 
indicate the standard deviation of two measurements. 
If the cell membrane were damaged too strongly, enzymes would be released into the 
extracellular medium. These enzymes would then be removed by washing of the cells prior to 
the assay resulting in reduced G6PDH activity. Additionally, enzymes may be inactivated by 
detergents or solvents applied at high concentrations. Since the activity determined in cells 
permeabilized with 0.3% v/v Triton X-100 was even slightly higher than that of the cell 
extract, we can assume that inactivation of enzymes is negligible at the used concentration. As 
Triton X-100 concentrations of 0.2% and 0.4% showed comparable results, the procedure is 
quite robust in this respect.In the next step the washed permeabilized cells were incubated 
with UDP-glucose and NAD
+
. As shown in Figure III-2a UDP-glucose was fully oxidized to 
UDP-glucuronic acid within 3 hours of reaction. By-product formation can be excluded as the 
only substrate was fully converted into the desired product. When the permeabilized parent 
strain NCYC2036 was applied instead of the recombinant strain no UDP-glucuronic acid was 
formed and no UDP-glucose was consumed. To potentially increase enzyme activity the 
experiment was repeated with 1 mM MgSO4 added to the reaction buffer.  
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Figure III-2. Synthesis of UDP-glucuronic acid from UDP-glucose. The synthesis of UDP-
glucuronic acid was carried out in 50 mM NH4HCO3 buffer at pH 7.8 and a cell concentration of 24 
g cell dry weight l
-1
. Temperature was kept at 30 °C and the mixture was shaken at 450 rpm 
(Thermomixer Comfort, Eppendorf). The reaction volume was 1 ml. Error bars indicate the 
standard deviation of two measurements. a Initial substrate and cofactor concentrations: UDP-
glucose 5 mM, NAD
+
 10 mM. b Hydrolysis of UDP-glucose in the presence of MgSO4. Initial 
substrate and cofactor concentrations: UDP-glucose 5 mM, NAD
+
 10 mM, MgSO4 1 mM. 
As can be seen in Figure III-2b Mg
2+
 profoundly impedes product formation. Only small 
amounts of glucuronic acid are formed while UDP-glucose is completely consumed. This 
effect is most likely related to the stimulating effect of Mg
2+
 on enzymes which hydrolyze 
UDP-sugars (Glaser et al. 1967). These findings highlight the importance of a well-designed 
substrate mixture. 
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An increase in substrate concentration from 5 mM to 10 mM led to an increase in the amount 
of product formed from 5 mM to 7 mM (Figure III-3). A further substrate increase to 15 mM 
resulted in an even less complete conversion with a final concentration of 7.2 mM (Figure III-
3). In each of these experiments the UDP-glucose consumed was completely converted to 
UDP-glucuronic acid (100±2%) indicating the absence of any side reaction. The sharp 
decrease in product formation at higher concentrations can be explained by inhibition of 
UGDH by high UDP-glucuronic acid concentrations (Banerjee and Bhattacharyya 2011; 
Hung et al. 2007). 
 
Figure III-3. Consumption of UDP-glucose and production of UDP-glucuronic at different initial 
substrate concentrations. a Concentration time courses. Initial substrate concentrations: Squares: 
UDP-glucose 5 mM, NAD
+
 10 mM; Triangles: UDP-glucose 10 mM, NAD
+
 20 mM; Diamonds: 
UDP-glucose 15 mM, NAD
+
 30 mM. The synthesis of UDP-glucuronic acid was carried out in 50 
mM NH4HCO3 buffer at pH 7.8. Cell density was 24 g cell dry weight l
-1
 in each experiment. 
Temperature was kept at 30 °C and the mixture was shaken at 450 rpm. Error bars indicate the 
standard deviation of two measurements. b Final product concentration as function of initial 
substrate concentration.  
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When cell extracts were applied instead of permeabilized cells, no product formation and no 
substrate consumption were observed at all. This indicates that the hexameric UGDH 
complex was disrupted during cell lysis.  
Next we attempted to replace the expensive substrate UDP-glucose with its precursors uridine 
mono phosphate (UMP) and glucose-1-phosphate (G1P) (Weyler and Heinzle 2015). In this 
setup UMP is first converted into UTP consuming 2 ATP. UTP and G1P then form UDP-
glucose. Under these conditions no UDP-glucose and no UDP-glucuronic acid were detected. 
We concluded that UDP-glucose formation requires Mg
2+
 to be active and indeed, when 
synthesis was repeated in the presence of 1 mM Mg
2+
, the yield of UDP-glucuronic acid was 
12% after 5 hours of reaction (Figure III-4). The concentration of UDP-glucose remained 
below the detection limit of about 0.01 mM during the whole experiment.  
 
Figure III-4. Synthesis of UDP-glucuronic acid starting from UMP. Initial substrate and cofactor 
concentrations: Squares: UDP-glucose 5 mM, NAD
+
 10 mM. Circles: UMP 5 mM, ATP 10 mM , 
G1P 5 mM, NAD
+
 10 mM, MgSO4 1 mM. The synthesis of UDP-glucuronic acid was carried out in 
50 mM NH4HCO3 buffer at pH 7.8. Cell density was 24 g cell dry weight l
-1
 in each experiment. 
Temperature was kept at 30 °C and the mixture was shaken at 450 rpm. Error bars indicate the 
standard deviation of two measurements. 
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After 5 hours of reaction UMP was completely used up as detected using MALDI-ToF. We 
assume that UMP was mostly consumed by hydrolysis reactions activated by Mg
2+
 (Proudfoot 
et al. 2004). 
In general, production with permeabilized cells is fast and relatively inexpensive and the 
catalyst can easily be separated from the reaction mixture via centrifugation or filtration. We 
showed that UDP-glucuronic acid can be synthesized from UDP-glucose with a 100% yield 
by applying permeabilized cells. In this well-defined system no formation of by-products was 
observed. Further improvements to this system would include the introduction of a 
regeneration system for NAD
+
, e.g., applying NADH oxidase (Hummel and Riebel 2003) as 
well as an optimized supply system for UDP-glucose, for example by using a strain that 
overexpresses the endogenous UDP-glucose pyrophosphorylase fyu1 (Buchheit et al. 2011a). 
Molecular engineering of UGDH towards reduced product inhibition could also be attempted. 
3. Materials & methods 
Strain S. pombe CAD 201 was provided by PomBioTech GmbH. Its parent strain S. pombe 
MB 163 harbors a deletion in the ura4 gene inducing uracil auxotrophy in this strain. The 
pCAD-UGDH plasmid which carries an intact ura4 gene and the human UGDH gene was 
introduced into the MB 163 strain. After integration of this plasmid into the leu1 gene of MB 
163 the resulting S. pombe CAD 201 strain exhibited leucine auxotrophy while ura4 was 
reinstalled. All cultivations were carried out in Edinburgh Minimal Medium supplemented 
with 1 mM leucine at 30 °C and 230 rpm in baffled shake flasks. 
Cells were harvested by centrifugation (6000×g, 12 min, 4°C) (Biofuge stratos, Heraeus, 
Hanau, Germany). The pelletized cells were then re-suspended in tris buffer (100 mM 
tris(hydroxymethyl)-aminomethan, 200 mM KCl, pH 7.8 with HCl) and centrifuged as 
before. After adjusting cell density to 6 g/l CDW in tris buffer 0.3% v/v triton were added and 
the mixture was incubated at room temperature for 60 minutes at 40 rpm for permeabilization. 
To assess the degree of permeabilization a glucose6-phosphate dehydrogenase (G6P-DH E.C. 
1.1.1.49) assay was used. 950 µl of assay solution were added to 50 µl of cell suspension or 
cell free extract to initiate the reaction. Final concentrations were: MgSO4 5 mM, NAD
+ 1 
mM, glucose 6-phosphate (G6P) 10 mM, NH4HCO3 50 mM and permeabilized cells 0.675 
g/l. Reaction pH was 7.8. UV absorption at 340 nm was measured to follow the formation of 
NADH (Spectronic Unicam, Helios α-Spectronic Analytical Instruments, West Yorkshire, 
UK). After permeabilization cells were washed three times with NH4HCO3 buffer (50 mM 
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NH4HCO3). The synthesis of UDP-glucuronic acid was carried out in 50 mM NH4HCO3 
buffer at pH 7.8 and a cell concentration of 24 g/l CDW. Temperature was kept at 30 °C and 
the mixture was shaken at 450 rpm (Thermomixer Comfort, Eppendorf, Hamburg, Germany). 
The reaction volume was 1 ml. All reactions were carried out in 2 ml Eppendorf tubes. For 
sampling 40 µl of reaction mixture were pipetted into 500 µl Eppendorf tubes and centrifuged 
at 16000×g for 1 minute. 30 µl of supernatant were then diluted by adding 720 µl of 
NH4HCO3 buffer (25 fold dilution) prior to HPLC analysis. The LC measurements were 
performed on an Infinity 1290 system (Agilent Technologies, Santa Clara, Kalifornien) using 
a Supelco Supelcosil LC-18-T HPLC Column (15cm*3mm; 3µm). Injection volume was 20 
µl and flowrate was 0.5 ml/min. Analysis was carried out isocratically in 100 mM NaH2PO4 
buffer (pH = 5,5 with KOH) in 20 minutes. For detection UV absorption at 260 nm was 
measured. Standard curves of UDP-glucose and UDP-glucuronic acid were recorded for 
quantification of these compounds. For MALDI analysis 4 µl of diluted sample were mixed 
with 8 µl of 9-aminoacridin (9 g/l in methanol). Samples were then analyzed with matrix 
assisted laser desorption ionization mass spectrometry (MALDI 4800 TOF/TOF Analyzer, 
Applied Biosystems, Darmstadt, Germany) in negative reflector mode. A pulsed 200 Hz 
Nd:YAG Laser with a wavelength of 355 nm was used for ionization. Laser energy was set to 
3200 units. Cell free extracts were generated by glass-beads treatment. 500 µl of cell 
suspension (12 g/l CDW) were mixed with 500 µg of glass beads (<0.25 mM in diameter) in a 
2 ml Eppendorf tube and shaken for 15 min at 30 Hz at 0-4 °C using a swing mill of type 
mM301 (Retsch GmbH, Haan, Germany). The mixture was then centrifuged at 16000g and 
4 °C for 15 min using Biofuge Fresco (Heraeus, Germany) to separate cell debris and 
supernatant. All Chemicals were purchased from Fluka (Buchs, Switzerland), Sigma-Aldrich 
(Steinheim, Germany), or Merck (Darmstadt, Germany) and were of analytical grade. 
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IV. Synthesis of the Cyclic Nonribosomal 
Peptide Luminmide and Synthetic 
Derivatives in Permeabilized Cells 
and Product Formation Kinetics. 
 
ABSTRACT 
 We used a recombinant, permeabilized Escherichia coli strain harboring the plu3263 gene 
cluster from Photorhabdus luminescens for the synthesis of luminmide type cyclic 
pentapeptides belonging to the class of nonribosomally biosynthesized peptides (NRP). Cells 
could be fully permeabilized using 1% v/v toluene. Synthesis of luminmides was increased 
fivefold when 0.3 mM EDTA was added to the substrate mixture. In this setup EDTA acts as 
an inhibitor of metal proteases. Luminmide formation was studied applying different amino 
acid concentrations. Apparent kinetic parameters for the synthesis of the main product 
luminmide A from leucine, phenylalanine and valine were calculated from the collected data. 
Ks
app
 values ranged from 0.17 mM for leucine to 0.63 mM for phenylalanine and rmax
app
 was ≈ 
2×10
-8
 mol/((g CDW) min). By removing phenylalanine from the substrate mixture, the 
formation of luminmide A was reduced tenfold while luminmide B was increased from 50 to 
500 µg/l becoming the main product. Two new luminmides were synthesized in this study. 
Luminmide H incorporates tryptophan replacing phenylalanine in luminmide A. In luminmide 
I leucine was replaced with 4,5-dehydro-leucine, a non proteinogenic amino acid fed to the 
incubation mixture. 
 
 
 
 
 
The chapter “Synthesis of the Cyclic Nonribosomal Peptide Luminmide and Synthetic 
Derivatives in Permeabilized Cells and Product Formation Kinetics.” is to be submitted in 
2015.  
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1. Introduction 
Drugs based on secondary metabolites are of great interest especially in case of antibiotics 
and anti-cancer agents. The rise of pathogens with multiple antibiotic resistances creates a 
permanent need for development of new antimicrobial agents (Walsh 2008; WHO 2014). 
Often these compounds are synthesized by large enzyme complexes known as 
megasynthetases. The largest classes of antimicrobial secondary metabolites are polyketides 
produced by polyketide synthases (PKS) and non-ribosomal peptides synthesized by non-
ribosomal peptide synthetases (NRPS)(Donadio et al. 2007). As purification of these large 
enzyme complexes in an active form is challenging and in many cases not possible, kinetic 
parameters have so far been determined for only very few of these synthases only (Wilson et 
al. 2013). We selected the NRPS producing luminmides since the corresponding gene cluster 
were recently expressed in E. coli (Fu et al. 2012). Luminmides are cyclic pentapapetides 
incorporating D and L amino acids. They were first described in 2012 as luminmides (Fu et al. 
2012) and in parallel as GameXpeptides (Bode et al. 2012). The megasynthase which 
produces these compounds is encoded by the plu3263 gene cluster from Photorhabdus 
luminescens. The NRPS consists of 18 catalytic subunits organized in 5 modules. In each 
module the peptide chain is elongated by one amino acid and subsequently transferred to the 
next module. In the last module the pentapeptide is released from the enzyme complex by 
cyclization. The two main products of the enzyme are depicted in Figure IV-1. The plu3263 
gene cluster was introduced into E. coli Nissle in 2012 (Fu et al. 2012) resulting in the 
synthesis of luminmides by this strain. 
 
Figure IV-1. Structures of luminmides A and B. 
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In 2015 the same group demonstrated the formation of five other luminmide derivatives 
(luminmides C-G) by the same enzyme complex. Relative yields of luminmides could be 
changed by introduction of rationally constructed single and double point mutations into one 
of the enzyme´s adenylation domains (Bian et al. 2015).  
Permeabilized cells have been used to study cellular metabolism since the 1960s (Felix 1982; 
Heinzle et al. 2013; Niklas et al. 2011). When cells are treated with surfactants i.e. detergents 
or solvents, their membrane can become permeable to small molecules while macromolecules 
including enzymes remain within the cellular envelope (Cánovas et al. 2005; Thedei et al. 
2008; Yuan and Heinzle 2009). After washing away low molecular weight compounds, the 
remaining “enzyme bags” can be used as multi-enzyme catalyst. This method has been 
successfully applied to the synthesis of UDP-glucose (Weyler and Heinzle 2015) as well as 
polyketides flaviolin (Krauser et al. 2012) and oxytetracycline (Krauser et al. 2015). A similar 
approach was used for the preparative scale production of UDP-glucose and other nucleotid 
sugars (Koizumi et al. 2000; Koizumi et al. 1998).  
The application of permeabilized cells is an efficient alternative to in vitro methods when it 
comes to determining enzyme kinetics. Additionally, it allows studying enzyme complexes in 
a close-to-natural environment while maintaining control of reaction conditions. In the present 
study we applied the concept of permeabilized cells to synthesize new luminmides, modify 
substrate selectivity and to gain insights into the kinetics of luminmide synthesis.  
2. Results & discussion 
2.1 Cell permeabilization.  
Permeabilized cells were applied to study and modify luminmide synthesis. First optimal 
conditions for cell permeabilization were determined. Glucose-6-phosphate dehydrogenase 
(G6PDH) activity was used to characterize the degree of permeabilization and enzyme 
integrity. In contrast to E. coli strains used in previous studies (Heinzle et al. 2013; Krauser et 
al. 2015; Krauser et al. 2012; Weyler and Heinzle 2015), detergents like Triton X-100 and 
Tween 80 showed little effect on the E. coli Nissle strain used in this project. G6PDH 
activities in cells permeabilized using toluene were similar to those in cell lysate (Supporting 
information, Figures S1 and S2). A toluene concentration of 1% v/v was found optimal 
allowing full permeabilization of the cells with a G6PDH activity identical to cell lysate. 
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However, no luminmide formation was observed when cell lysate was applied instead of 
permeabilized cells (Figure S15 of the supporting information). 
2.2 Boosting luminmide synthesis.  
Initial experiments showed that product concentration starts decreasing after 4 hours of 
reaction. This is shown in Figure S14 in the supporting information. We hypothesized that 
proteases were responsible for product degradation. To avoid luminmide degradation, the 
effect of protease inhibitors on product formation was studied. Initially a protease inhibitor 
cocktail dissolved in 20% DMSO was applied. In these experiments luminmide formation 
was substantially increased at low inhibitor concentrations whereas it was approaching zero 
values at high concentrations (Figure S3). Further studies identified EDTA as a most suitable 
protease inhibitor. The same effect as with a corresponding amount of cocktail was observed 
with this agent. This indicates that the other components of the cocktail have no effect on 
luminmide formation and stability. The effect of EDTA is shown in Figure IV-2. It can be 
concluded that EDTA strongly inhibits degradation of luminmides. At 0.3 mM EDTA does not 
significantly reduce available Mg2+ which is present at 5 mM. 
 
Figure IV-2. Formation of luminmide A in permeabilized cells in the presence of different 
concentrations of EDTA. Leucine, phenylalanine and valine concentrations were 5 mM each. 
Luminmide A was measured @ 586.4 ± 0.2 m/z. 
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At the same time zinc proteases are effectively inhibited as EDTA has much higher affinity 
for zinc than for magnesium. The EDTA(Zn
2+
) complex is about 8 orders of magnitude more 
stable than the EDTA(Mg
2+
) complex (Furia 1972; Kołodyńska 2011). 
2.3 Studies on luminmide A  
When leucine, valine and phenylalanine are present, the main product of the plu3263 NRPS 
complex is luminmide A (Figure IV-1). In vivo luminmide A is primarily produced as well 
(Bian et al. 2015; Fu et al. 2012). Studying enzyme kinetics usually requires extensive 
enzyme purification (Wilson et al. 2013). However, when proteins are extracted, enzyme 
complexes are usually destroyed not permitting kinetic analysis. If cells are permeabilized 
under mild enough conditions, enzyme complexes are expected to remain close to their in 
vivo state. Therefore, they are still active allowing the study of their characteristics under 
defined conditions. We used this method to carry out kinetic analyses of the plu3263 complex. 
As expected, product formation increased with increased substrate concentration as shown for 
phenylalanine in Figure IV-3. In further experiments valine and leucine concentrations were 
varied, and product formation patterns were qualitatively similar to those depicted in Figure 
IV-3 (Figures S4 and S5 of the supporting information). We believe the initial lag phase 
occurs due to the loading of the product formation chain. The kinetic behavior of the enzyme 
after this lag phase was analyzed using simple saturation kinetics (Figures S6 to S8 of 
supporting information). As we related product formation to substrate consumption all kinetic 
parameters determined are apparent parameters. We are aware that a complete kinetic 
description of the NRPS at hand would be extremely complex. However, a detailed 
elucidation of the kinetic behavior of the plu3263 enzyme complex is beyond the scope of this 
study. Gaining insight into the behavior of the five reaction modules as well as each of the 18 
catalytic domains would require cloning and purification of each individual module. We 
attempt here a first overall description of the macroscopic kinetics of plu3263 complex after 
its lag phase. Apparent kinetic parameters derived from our data are presented in Table IV-1. 
In these experiments only a small fraction of the amino acids, i.e. less than 2%, was consumed 
and even less incorporated into luminmides (Supporting material, Table S2). 
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Figure IV-3. Synthesis of luminmide A by permeabilized cells. Initial valine and leucine 
concentrations were 5 mM each. Cell density was 27 mg/ml CDW. Luminmide A was measured @ 
586.4 ± 0.2 m/z. 
 
Table IV-1. Kinetic findings on luminmide synthase. Cell density was 27 mg/ml CDW. Complete 
data are provided in the supporting information (Figures S4 to S8). rmax
app – maximal rate with 
respect to permeabilized cell concentration. As calculations were based on product formation values 
given for Ks
app and rmax
app are apparent parameters. 
 
As shown in Figures IV-3 as well as in Figures S4 and S5 in the supporting material, product 
formation rate decreased after 16 hours of reaction. So far concentrations higher than 0.7 mg/l 
have not been detected. To distinguish between product inhibition and enzyme inactivation, 
cells were washed twice with KH2PO4 buffer after 35 h of reaction. The washed cells were 
then incubated with a fresh substrate cocktail containing leucine, phenylalanine and valine (5 
mM each). In this batch only trace amounts of luminmides were detected after 22 h of 
Varied Substrate Non varied substrates K s
app  (mM) r max
app
 (mmol min
-1
 g (CDW)
-1
)
Leu (0.04-5 mM) Val, Phe (5 mM each) 0.18 ± 0.06 (2.93 ± 0.11) × 10-8
Val  (0.04-5 mM) Leu, Phe (5 mM each) 0.57 ± 0.08 (3.33 ± 0.15) × 10-8
Phe (0.04-5 mM) Leu, Val  (5 mM each) 0.57 ± 0.15 (3.61 ± 0.32) × 10-8
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reaction (Figure S15 of the supporting information). We conclude that the decrease in product 
formation rate after 16 h can be explained by enzyme inactivation rather than via product 
inhibition. This may be due to an increasing percentage of NRPS inactivated by mispriming 
with amino acids not suited for subsequent elongation. When an A-domain loads an amino 
acid which is not suited for its corresponding C-domain, the assembly line is blocked and the 
involved NRPS complex cannot synthesize any more product. This can be reversed if the 
amino acid is cleaved off by an enzyme (Schwarzer et al. 2002; Yeh et al. 2004).  
With our method we cannot determine kinetics of individual reaction steps (adenylation, 
peptidyl-transfer, condensation, epimerization or macrocyclization). However, it allows 
gaining insight into the kinetics of complex enzymes without extensive enzyme purification. 
To prevent inactivation, enzyme immobilization using glutaraldehyde was attempted. 
However, no increase in productivity could be achieved using this method. At low 
glutaraldehyde concentrations luminmide production was not influenced while higher 
concentrations led to a complete stop in product formation. We assume that high cross linker 
concentrations limit the structural flexibility of the enzyme complex which is required for 
catalytic activity. Data are summarized in Table S5 of the supporting information. 
2.4 Modifying substrate selectivity 
The availability of Phe results in the preferential synthesis of either luminmide A or B 
(Figures IV-4 and IV-5). If the cells are supplied with leucine, phenylalanine and valine, 
luminmide A is the main product. Under these conditions only small amounts of luminmide B 
are formed. The ratio between luminmide A and luminmide B is > 10. When phenylalanine 
was omitted in the substrate mixture, luminmide B formation was increased 10 fold reaching 
0.5 mg/l. At the same time only trace amounts of luminmide A were detected. Modifying 
product formation by NRPS complexes normally requires extensive genetic engineering (Bian 
et al. 2015; Calcott and Ackerley 2014; Eppelmann et al. 2002). The presented approach is 
fast and inexpensive for the creation of new variants of luminmides compared to cloning 
based methods. 
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Figure IV-4. Comparison of the formation of luminmides A and B in the presence and the absence 
of phenylalanine. Cell density was 27 mg/ml CDW. Luminmides A and B were measured @ 586.4 ± 
0.2 and 552.4 ± 0.2 m/z respectively. 
 
Figure IV-5. Comparison of the formation of luminmides A and B. The base peak chromatograms 
for 500-600 m/z are shown between 0 and 9 minutes. Both samples were taken after 35 h of 
reaction. In I the reaction mixture was supplied with 5 mM phenylalanine. In II no phenylalanine 
was added. Cell density was 27 mg/ml CDW.  
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2.5 New synthetic luminmides 
To gain insight into the substrate promiscuity of the enzyme complex, permeabilized cells 
were incubated with several proteinogenic and non proteinogenic amino acids. Table S1 of 
the supporting information lists these amino acids and their tentative luminmide derivatives. 
Resulting products were analyzed with LC-MS and further characterized using MS
2
. Two 
already previously identified derivatives, luminmide E and F (Bian et al. 2015), were found at 
concentrations of 26 and 25 µg/l, respectively. Two previously undescribed luminmides were 
detected in the corresponding studies. Luminmide H incorporates tryptophan in place of 
phenylalanine in luminmide A (Figure IV-6), as is supported by mass spectral data provided 
in the supporting information (Figure S10 and Table S4). The increase in polarity resulted in a 
reduction of retention time in the HPLC from 6.8 minutes (luminmide A) to 6.6 minutes. The 
determined concentration of luminmide H was 26 µg/l after 30 hours of reaction. Formation 
of luminmide H did not impede luminmide A formation and did not increase when 
phenylalanine was omitted in the reaction mixture. When leucine was replaced with 4,5-
dehydro-leucine, luminmide I, incorporating dehydro-leucine instead of leucine, was formed. 
Here retention time was reduced to 6.2 minutes. The tentative structure provided in Figure IV-
6 is supported by mass spectral data (Supporting information, Figure S11 and Table S5). An 
estimated 36 µg/l of luminmide I were detected after 30 hours of reaction. When leucine was 
added to the reaction mixture, no luminmide I could be detected while luminmide A synthesis 
was unaffected. Even when no leucine was supplied, small amounts of luminmide A were 
detected. Additionally, two derivatives incorporating one 4,5-dh-Leu and two Leu (584.47 
m/z, elutes after 6.6 min) as well as two dh-Leu and one Leu (582.47, elutes after 6.4 min) 
were measured. These observations can be explained assuming that the 4,5-dehydro-leucine 
used was contaminated with trace amounts of leucine. It can be concluded, that although dh-
Leu was incorporated into the luminmide frame, the plu3263 complex has much higher 
affinity for leucine.  
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Figure IV-6. Structures of luminmide derivatives newly identified in this study. Luminmides H and 
I were detected in positive mode at 625.5 and 580.42 m/z respectively. Amino acid sequences were 
identified based on MS2 data (Supporting information, Tables S4 and S5, Figures S10 and S11). 
Stereochemistry was assessed based on the known configuration of luminmides A and B. 
2.6 Conclusion 
We demonstrated that permeable cells can be used to synthesize non ribosomal peptides in 
situ. This approach allowed us to study luminmide formation under controlled conditions, 
enabling the determination of apparent kinetic parameters. As isolation of megasynthases in 
an intact form is extremely challenging and in many cases impossible due to the instability of 
these large complexes, the presented method is a viable route for such studies. Here no 
product formation was observed when cell extracts were applied. Gaining insight into 
individual reaction steps like adenylation, peptidyl-transfer, condensation, epimerization or 
macrocyclization still requires cloning of the corresponding catalytic modules. However, cell 
permeabilization can be applied to study overall enzyme kinetics in a straight forward 
manner. In the future, permeabilized cells might be used to study enzyme complexes with 
high throughput in a close to in vivo state. 
Furthermore, we could shift production from luminmide A to luminmide B by simply 
modifying the provided substrates. Traditionally, this kind of modification requires extensive 
enzyme engineering which is highly laborious in the case of large enzyme complexes. We 
speculate that our method could be applied to other NRPS complexes as well most likely 
giving access to previously inaccessible compounds. Additionally, the synthesis of luminmide 
I demonstrates the ability of the plu3263 complex to incorporate 4,5-dehydro-leucine, a non-
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natural amino acid. Additionally, our approach can be applied to test megasynthetases with 
substrates which cannot be supplemented in vivo especially if no activity is found in cell 
lysates. Overall, we showed that permeabilized cell synthesis is a powerful method for 
studying NRPS complexes and that it can help explore the full potential of these enzymes. 
3. Materials & methods 
E.coli Nissle 1917 plu3263 was previously described (Fu et al. 2012). This strain harbors the 
plu3263 gene cluster from Photorhabdus luminescens as well as an ampicillin resistance gene. 
Details concerning the gene cluster itself, as well as the cloning technique have been 
published earlier (Fu et al. 2012). All cultivations were carried out in TB medium (tryptone 12 
g/l, yeast extract 24 g/l, K2HPO4 9.4 g/l, KH2PO4 2.2 g/l, glycerol 4 ml/l and pH adjusted to 
7.2) at 30 °C and 230 rpm in baffled shake flasks. The growth medium was supplemented 
with 100 µg/ml ampicillin. Cells were harvested by centrifugation (6800×g, 7 min, 4°C) 
(Biofuge stratos, Heraeus, Hanau, Germany). The pelletized cells were then re-suspended in 
phosphate buffer (50 mM KH2PO4, pH 7.8 with KOH) and incubated with 1% v/v toluene for 
permeabilization. Then permeabilized cells were washed three times with phosphate buffer. 
Cell density was adjusted to 27 mg/ml CDW.  
Glass-bead treatment was used to generate cell free extracts. 500 µl of cell suspension (27 
mg/ml CDW) were mixed with 500 µg of glass beads (<0.25 mM in diameter) in a 2 ml 
Eppendorf tube and shaken for 15 min at 30 Hz at 0-4 °C using a swing mill of type mM301 
(Retsch GmbH, Haan, Germany). The mixture was then centrifuged at 16000×g and 4 °C for 
15 min using Biofuge Fresco (Heraeus, Germany) to separate cell debris and supernatant. 
Enzyme immobilization was attempted using the crosslinking agent glutaraldehyde. After 
permeabilization cells were washed twice using phosphate buffer as described above. Then 
pelletized cells were resuspended in the same buffer supplemented with 0, 0.1, 0.25, 0.5, 1 or 
2% w/v glutaraldehyde. Cell density was adjusted to 27 mg/ml CDW. Cells were incubated 
for 30 minutes at 4 °C. In the next step cells were washed three times with above described 
KH2PO4 buffer. As with untreated cells cell density was adjusted to 27 mg/ml CDW.  
The applied protease inhibitor cocktail was specific for bacterial cells. It was purchased from 
Sigma. Product number is P 8465. It contained AEBSF 23 mM, EDTA 100 mM, Bestatin 2 
mM, pepstatin A 0.3 mM and E-64 0.3 mM dissolved in 20% DMSO. Amounts ranging from 
100 µl/ml to 3 µl/ml were applied. 
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The synthesis of luminmides was carried out in 50 mM KH2PO4 buffer at pH 7.8 and a cell 
concentration of 27 g/l CDW in the presence of 20 mM ATP, 5 mM MgSO4, 0.3 mM EDTA. 
For the synthesis of luminmide H 5 mM tryptophan was added to the reaction mixture instead 
of phenylalanine. In the case of luminmide I 5 mM 4,5-dehydro-leucine was used instead of 
leucine. Concentrations of leucine, phenylalanine and valine were 5 mM unless otherwise 
stated. Temperature was kept at 30 °C and the mixture was shaken at 450 rpm (Thermomixer 
Comfort, Eppendorf, Hamburg, Germany). The reaction volume was 1 ml. All reactions were 
carried out in 2 ml Eppendorf tubes.  
For sampling, 100 µl of reaction mixture were pipetted onto 300 µl of ethyl acetate in 1.5 ml 
Eppendorf tubes. This two phase mixture was shaken vigorously for 2 min. After 1 min 
centrifugation at 16000×g the supernatant (organic phase) was pipetted into 1.5 ml Eppendorf 
tubes and evaporated under reduced pressure. The remaining solid was dissolved in 100 µl of 
methanol prior to LC-MS analysis.  
The LC-MS measurements were performed on an Ultimate 3000 LC system (Dionex, 
Sunnyvale, CA, USA) using an Acquity BEH C-18, 50 x 2 mm, 1.7 µm dp column (Waters, 
Milford, MA, USA). Separation of 2 µl of sample was achieved by a linear gradient with (A) 
H2O + 0.1% FA (formic acid) to (B) ACN + 0.1% FA at a flow rate of 600 µl/min and 45 °C. 
The gradient was initiated by a 0.5 min isocratic step at 5% B, followed by an increase to 95% 
B in 9 min to end up with a 1.5 min step at 95% B before re-equilibration with initial 
conditions. The MS measurement was carried out on an amaZon speed mass spectrometer 
(BrukerDaltonics, Bremen, Germany) using the standard ESI source. Mass spectra were 
acquired in centroid mode ranging from 200 – 2000 m/z in positive ionization mode with auto 
MS2 fragmentation. Mass spectra were analyzed using Bruker Compass Data analysis 4.1 SR1 
(Bruker Corporation, Billerica, USA). Luminmide derivatives were identified using MS2 data 
as described in detail in the supporting information. 
For quantification of Luminmide A the (extracted ion chromatogram) EIC of 586.43 ± 0.3 m/z 
was integrated and the area of the peak eluting after 6.8 min was used. For quantification of 
Luminmide B the EIC of 552.45 ± 0.3 was used. Luminmide B elutes after 6.7 min. 
Quantification of other Luminmide derivatives is described in the supporting information. 
For parameter estimation (Table IV-1) saturation kinetics were applied to fit the measured 
data with a Levenberg Marquardt iteration algorithm using Origin 2015G (OriginLab 
Corporation, Northampton, USA). Details are described in chapter 3 of the supporting 
material. 
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All Chemicals were purchased from Fluka (Buchs, Switzerland), Sigma-Aldrich (Steinheim, 
Germany), or Merck (Darmstadt, Germany) and were of analytical grade. 
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1. Cell permeabilization 
 To determine the degree of cell permeabilization a glucose6-phosphate dehydrogenase (G6P-
DH E.C. 1.1.1.49) assay was used. 950 µl of assay solution were added to 50 µl of cell 
suspension or cell free extract to initiate the reaction. Final concentrations were: MgSO4 5 
mM, NAD+, 1 mM, glucose 6-phosphate (G6P) 10 mM, KH2PO4 50 mM and permeabilized 
cells 1.35 mg/ml. Reaction pH was 7.8. UV absorption at 340 nm was measured to follow the 
formation of NADH (Spectronic Unicam, Helios α-Spectronic Analytical Instruments, West 
Yorkshire, UK). The reaction temperature was kept at 30°C using a water bath. As shown in 
Figure S1, toluene is well suited for cell permeabilization if applied at 1% v/v. Identical 
results were observed when 1.5% toluene were applied. At higher toluene concentrations 
increasing G6P-DH activity was observed in the supernatant indicating partial disruption of 
the cellular envelope causing release of enzymes into the environment. The effect of several 
other common permeabilizing agents/methods was also studied. Results are given in Figure 
S2. Sodium dodecyl sulfate (SDS), Tween 80 and N-lauroylsarcosine gave results very similar 
to Triton X-100 (not shown). 
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Figure S1. G6PDH activity in E.coli Nissle cells permeabilized with different amounts of toluene. The 
activity of cell lysate is shown as reference. Incubation time with toluene was 30 min @ 30 °C. Cells 
were washed twice after the toluene treatment and prior to the assay.  
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Figure S2. G6PDH activity in E.coli Nissle cells permeabilized with different permeabilization 
techniques. The activity of cell lysate is shown as reference. Incubation time with Triton X-100, 
hexadecyl-trimethyl-ammonium bromide (CTAB) and ethylenediaminetetraacetic acid (EDTA) (10 
mM) was 10 min @ 30 °C. In the freeze thaw/process 1 ml of cell suspension was frozen @ -75 °C for 
20 minutes and then thawed @ 23 °C in a water bath. Cells were washed twice after the 
permeabilizing treatment and prior to the assay. 
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2. Effect of protease inhibitor cocktail 
The influence of the addition of varying amounts of protease inhibitor cocktail to the reaction 
mixture is depicted in Figure S3. 
 
Figure S3. Formation of luminmide A in permeabilized cells in the presence of different amounts 
of protease inhibitor cocktail*. Leucine, phenylalanine and valine concentrations were 5 mM each. 
Luminmide A was measured @ 586.4 ± 0.2 m/z. 
*1 Vol% of inhibitor cocktail corresponds to 1 mM EDTA as the cocktail contains 100 mM EDTA. 
3. Kinetic studies 
To gain insight into the kinetics of product formation, the synthesis of luminmide A was 
observed at different amino acid concentrations. ATP was supplied at 20 mM concentration, 
i.e. a high molar excess. For sampling, 100 µl of reaction mixture were pipetted onto 300 µl 
of ethyl acetate in 1.5 ml Eppendorf tubes. This two phase mixture was shaken vigorously for 
2 min. After 1 min centrifugation at 16000×g the supernatant (organic phase) was pipetted 
into 1.5 ml Eppendorf tubes and evaporated under reduced pressure. The remaining solid was 
then dissolved in 100 µl of methanol prior to LC-MS analysis.  
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Product formation kinetics were described as  
max
S
P
S S
C
r r
K C


  
where CS is the substrate concentration [mM], rmax the maximum formation rate (mmol/g cell 
min) and KS the saturation constant [mM]. The ATP concentration of 20 mM represents a 
saturation concentration since the addition of more ATP did not change the formation rate. 
 
Figure S4. Formation of luminmide A at different leucine concentrations. Cell dry weight was 27 
mg/ml. Concentration of other substrates and cofactors: valine 5 mM, phenylalanine 5 mM, ATP 20 
mM, MgSO4 5 mM. The temperature was kept at 30 °C and the mixture was shaken at 450 rpm. 
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Figure S5. Formation of luminmide A at different valine concentrations. Cell dry weight was 27 
mg/ml. Concentration of other substrates and cofactors: phenylalanine 5 mM, leucine 5 mM, ATP 20 
mM, MgSO4 5 mM. The temperature was kept at 30 °C and the mixture was shaken at 450 rpm. 
 
 
Figure S6. Maximum rates of luminmide formation vs valine concentration. Rates were derived from 
the data shown in Figure S5 (100 - 1200 min). Saturation kinetics was used to fit the measured data 
using Origin 2015G (OriginLab Corporation, Northampton, USA).  
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Figure S7. Maximum rates of luminmide formation vs leucine concentration. Rates were derived from 
the data shown in Figure S4 (100 - 1200 min). Saturation kinetics was used to fit the measured data 
using Origin 2015G (OriginLab Corporation, Northampton, USA). 
 
 
Figure S8. Maximum rates of luminmide formation vs phenylalanine concentration. Rates were 
derived from the data shown in Figure IV-3 (main paper) (100 - 1100 min for 5, 1 and 0.2 mM Phe 
and 100- 700 min for 0.04 mM Phe). Saturation kinetics was used to fit the measured data using 
Origin 2015G (OriginLab Corporation, Northampton, USA). 
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4. Applied alternative amino acids 
The amino acids given in Table S1 were used to replace L-Phe or in the case of 4,5-dh-Leu, 
L-Leu in the substrate mixture. 
Concentrations of luminmides E, F, H and I were estimated based on the calibration for the 
luminmide A standard. 
Table S1: Applied alternative amino acids and tentative variants of luminmides. In the reaction batch 
with 4,5-dehydro-leucine, Val and Phe concentrations were 5 mM each. In all others Leu and Val 
concentrations were 5 mM each. 
Alternative 
amino acid 
Concentra-
tion (mM) 
Tentative luminmide structure 
Detected 
concentration 
(µg l-1)* 
Ratio new 
luminmide/ 
luminmide A 
L-cysteine 5 D-Val—L-Leu—D-Cys—D-Leu—L-Leu n.d. 0 
DL-DOPA 2.5 D-Val—L-Leu—D-DOPA—D-Leu—L-Leu n.d. 0 
4,5-dehydro-
leucine 
5 
D-Val—L-4,5-dh-Leu—D-4,5-dh-Leu—D-4,5-dh-Leu—L-4,5-dh-Leu 
Luminmide I  
36 0.97 
L-methionine 5 
D-Val—L-Leu—D-Met—D-Leu—L-Leu 
Luminmide F 
25 0.83 
L-serine 5 D-Val—L-Leu—D-Ser—D-Leu—L-Leu n.d. 0 
L-tryptophan 5 
D-Val—L-Leu—D-Trp—D-Leu—L-Leu 
Luminmide H 
26 
0.86 
 
L-tyrosine 2.5 
D-Val—L-Leu—D-Tyr—D-Leu—L-Leu 
Luminmide E 
26 0.86 
*After 35 hours of reaction for luminmides E,F and H and after 32 hours for luminmide I. 
L-Methionine and L-tyrosine derived luminmides (luminmide F and E) have been previously 
described (Bian et al. 2015). 
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5. Reactions consuming amino acids  
As shown in Table S1 small amounts of luminmide A were detected in each experiment. As 
determined using agar plates a very small fraction of cells (1- 10 cells in 10
7
 cells) remained 
viable after permeabilization. Several dilutions of permeabilized and non permeabilized cells 
(1000 fold to 10
9
 fold dilution, 10 fold dilution in each step) were plated and the number of 
colonies was compared.). These cells could import phenylalanine and other intracellular 
metabolites into the reaction mixture inducing the formation of low amounts of luminmide A, 
as well as enabling other reactions which consume amino acids. Amino acid measurements 
given in Table S2 support this hypothesis. When applied in high concentrations, more amino 
acids were consumed than were incorporated into the luminmide structure. At lower 
concentrations hardly any changes in amino acid concentrations were observed.  
Table S2. Amino acid consumption at different starting concentrations. In each experiment two 
amino acids were at 5 mM while one was at 5, 1, 0.2 or 0.04 mM. In all cases initial ATP 
concentration was 20 mM.  
 
a
 Concentrations indicated in this column were calculated based on the amount of luminmide A formed.  
b
 Determination of amino acid concentrations was not sufficiently sensitive to determine the fraction of amino 
acid integrated into luminmide A at low (0.2 and 0.04 mM) amino acid concentrations. 
 
Initial 
concentration 
(mM)
Concentration 
after 1220 min 
(mM)
Concentration 
after 2115 min 
(mM)
Amino acid 
consumed after 
2115 min (µM)
Amino acid 
integrated into 
luminmide A after 
2115 min (µM)a
Fraction of amino 
acid integrated 
into luminmide A 
per amino acid 
consumed 
L-Leu 5.001 4.987 4.967 34 3.6 0.11
L-Phe 5.000 4.980 4.952 48 1.2 0.03
L-Val 4.997 4.991 4.980 17 1.2 0.07
L-Leu 1.002 1.001 0.997 5 2.7 0.54
L-Phe 1.000 0.998 0.990 10 0.9 0.09
L-Val 1.002 1.002 1.000 2 0.7 0.34
L-Leu 0.205 0.205 0.204 1 1.5 --b
L-Phe 0.197 0.197 0.196 1 0.2 0.17b
L-Val 0.198 0.198 0.198 0 0.3 --b
L-Leu 0.040 0.040 0.040 0 0.9 --b
L-Phe 0.039 0.039 0.039 0 0.1 --b
L-Val 0.039 0.039 0.040 (-1) 0.2 --b
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At all concentrations amino acid consumption was higher than the amount of amino acid 
integrated into luminmide A. However, in each case relative changes in overall amino acid 
concentration were below 1% (except in the case of L-Val at 0.04 mM where it was 2.5%). 
These small changes cannot significantly interfere with kinetic measurements.  
6. Identification of luminmide derivatives 
Luminmides were indentified using MS
2
 fragmentation. Luminmide A data served as 
reference for the identification (Figure S9 and Table S3). The fragmentation patterns and 
tables highlighting the fragments used for structure determination of new derivatives are 
shown in Figures S10 and S11 and in the respective Tables S4 and S5. Spectra of previously 
described luminmides F and E are depicted in Figures S12 and S13. Concentrations of 
luminmides H and I were estimated based on the calibration for the luminmide A standard. 
Luminmide A 
 
Figure S9. MS
2
 of Luminmide A.  
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Table S3. Characteristic mass fragments from the MS
2
 pattern of a luminmide A standard.  
formula amino acids measured m/z 
calculated 
m/z 
eliminated 
molecules** 
C32H52N5O5 Leu,Leu,Leu,Phe,Val 586,48 586,4 none, parent ion 
C32H50N5O4 Leu,Leu,Leu,Phe,Val 568,43 568,39 H2O 
C31H52N5O4 Leu,Leu,Leu,Phe,Val 558,51 558,41 CO 
C31H49N4O4 Leu,Leu,Leu,Phe,Val 541,47 541,38 CO + NH3 
C27H43N4O4 Leu,Leu,Leu,Phe 487,4 487,33  
C26H41N4O4 Leu,Leu,Phe,Val 473,38 473,31  
C25H41N4O3 Leu,Leu,Phe,Val 445,34 445,32 CO 
C23H43N4O4 Leu,Leu,Leu,Val 439,4 439,33  
C25H38N3O3 Leu,Leu,Phe,Val 428,36 428,29 NH3 + CO 
C21H32N3O3 Leu,Leu,Phe 374,3 374,24  
C20H30N3O3 Leu,Phe,Val 360,24 360,23  
C17H32N3O3 Leu,Leu,Val 326,19 326,24  
C16H29N2O2 Leu,Leu,Val 281,23 281,22 NH3 + CO 
C15H21N2O2 LeuPhe 261,09 261,16  
C14H21N2O2 Leu,Phe 233,1 233,17 CO  
C12H23N2O2 Leu,Leu 227,11 227,18  
C11H21N2O2 Leu,Val 213,02 213,16  
 
**It was assumed that small, neutral molecules are preferably eliminated. Mass differences between 
measured m/z and calculated m/z for intact peptides were considered to deduce eliminated groups. 
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Luminmide H 
 
Figure S10. MS
2
 of luminmide H. Estimated concentration: 26 µg/l. 
 
Table S4. Mass fragments used for identification of luminmide H. 
formula amino acids 
measured 
m/z* 
calculated m/z 
eliminated 
molecules** 
C34H53N6O5 Leu,Leu,Leu,Trp,Val 625,51* 625,41 
none, parent 
ion 
C34H51N6O4 Leu,Leu,Leu,Trp,Val 607,46* 607,40 H2O 
C33H53N6O4 Leu,Leu,Leu,Trp,Val 597,53* 597,42 CO 
C33H50N5O4 Leu,Leu,Leu,Trp,Val 580,47* 580,39 CO + NH3 
C29H44N5O4 Leu,Leu,Leu,Trp 526,42* 526,34  
C28H42N5O4 Leu,Leu,Trp,Val 512,40* 512,32  
C28H44N5O3 Leu,Leu,Leu,Trp 498,43 498,35 CO  
C17H42N5O3 Leu,Leu,Trp,Val 484,43* 484,33 CO  
C17H39N4O3 Leu,Leu,Trp,Val 467,37* 467,30 CO + NH3 
C23H43N4O4 Leu,Leu,Leu,Val 439,31* 439,33  
C23H33N4O3 Leu,Leu,Trp 413,33* 413,26  
C22H31N4O3 Leu,Trp,Val 399,19* 399,24  
C17H32N3O3 Leu,Leu,Val 326,28* 326,24  
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C17H22N3O2 Leu,Trp 300,17* 300,17  
C16H22N3O Leu,Trp 272,15* 272,18 CO  
C12H23N2O2 Leu,Leu, 227,08* 227,18  
C11H21N2O2 Leu,Val 213,00* 213,16  
*Corresponding ions with respectively different m/z values 0f Trp or Phe containing fragments were also identified in the 
fragmentation pattern of luminmide A (Figure S9 and Table S3). Fragments unique for luminmide H are printed in bold. 
**It was assumed that small, neutral molecules are preferably eliminated. Mass differences between measured m/z and 
calculated m/z for intact peptides were considered to deduce eliminated groups. 
 
Luminmide I 
 
Figure S11. MS
2
 of Luminmide I. Estimated concentration: 36 µg/l. 
Table S5. Mass fragments used for identification of luminmide I.  
formula amino acids 
measured 
m/z 
calculated 
m/z 
eliminated 
molecules** 
C32H46N5O5 Dh-Leu,Dh-Leu, Dh-Leu,Phe,Val 580,42* 580,35 none, parent ion 
C32H43N4O5 Dh-Leu,Dh-Leu, Dh-Leu,Phe,Val 563,36 563,32 NH3 
C32H44N5O4 Dh-Leu,Dh-Leu, Dh-Leu,Phe,Val 562,40* 562,34 H2O 
C31H46N5O4 Dh-Leu,Dh-Leu, Dh-Leu,Phe,Val 552,44* 552,36 CO 
C31H43N4O4 Dh-Leu,Dh-Leu, Dh-Leu,Phe,Val 535,41* 535,33 CO + NH3 
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C27H37N4O4 Dh-Leu,Dh-Leu,Dh-Leu,Phe 481,32* 481,28  
C26H37N4O4 Dh-Leu,Dh-Leu,Phe,Val 469,34* 469,28  
C26H34N3O4 Dh-Leu,Dh-Leu,Phe,Val 452,33 452,25 NH3 
C25H37N4O3 Dh-Leu,Dh-Leu,Phe,Val 441,34* 441,29 CO 
C23H34N3O4 Dh-Leu,Dh-Leu,Dh-Leu,Val 416,28 416,15 NH3 
C21H28N3O3 Dh-Leu,Dh-Leu,Phe 370,25* 370,21  
C20H28N3O3 Dh-Leu,Phe,Val 358,17* 358,21  
C17H28N3O3 Dh-Leu,Dh-Leu,Val 322,2* 322,21  
C14H24N3O4 Dh-Leu,Dh-Leu,Val 298,22 298,17 
propene 
(C3H6)*** 
C13H22N3O4 Dh-Leu,Dh-Leu,Val 284,17 284,16 
2-
methylpropene 
(C4H8)*** 
C15H19N2O2 Dh-Leu,Phe 259,06* 259,15  
C14H19N2O2 Dh-Leu,Phe 231,11* 231,15 CO  
C12H19N2O2 Dh-Leu,Dh-Leu 223,03* 223,15  
C11H19N2O2 Dh-Leu,Val 211,00* 211,14  
 
*Corresponding ions with respectively different m/z values of Trp or Phe containing fragments were also identified in the 
fragmentation pattern of luminmide A (Figure S9 and Table S3). Fragments unique for luminmide I are printed in bold. 
**It was assumed that small, neutral molecules are preferably eliminated. Mass differences between measured m/z and 
calculated m/z for intact peptides were considered to deduce eliminated groups. 
***Proposed mechanism: Partial rearrangement of peptide with addition of H2O to Dh-Leu double bond prior to elimination 
reaction. 
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Figure S12. MS
2
 of Luminmide E. Estimated concentration: 26 µg/l. 
 
 
Figure S13. MS
2
 of Luminmide F. Estimated concentration: 25 µg/l. 
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7. Cell treatment with glutaraldehyde 
When cells were treated with glutaraldehyde, productivity was not increased. At 
concentrations of 0.5% m/v and above no lumnimides could be detected anymore indicating 
enzyme inactivation. Results are given in Table S6. 
Table S6. Luminmide A production by glutaraldehyde treated cells. 
 
Concentration of 
glutaraldehyde 
(% w/v) 
Concentration of 
Lumnimide A after 22 h (mg/l) 
Concentration of 
Lumnimide A after 46h 
(mg/l) 
0 0.5 0.6 
0.1 0.5 0.5 
0.25 n.d. n.d. 
0.5 n.d. n.d. 
1 n.d. n.d. 
2 n.d. n.d. 
 
8. Luminmide formation if no EDTA is supplied 
When no EDTA is added to the reaction mixture product concentration starts decreasing after 
4 hours of reaction. This behaviour is shown in Figure S14. 
 
Figure S14. Formation of luminmide A in permeabilized cells in the presence (circles) and the 
absence (squares) of EDTA. Leucine, phenylalanine and valine concentrations were 5 mM each. 
Luminmide A was measured @ 586.4 ± 0.2 m/z. 
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9. Activity of cell lysate and second incubation of used cells 
When permeabilized cells were replaced with cell lysate no luminmide formation could be 
observed. To distinguish between product inhibition and enzyme inactivation cells were 
washed twice with KH2PO4 buffer after 35 h of reaction. The washed cells were then 
incubated with a fresh substrate cocktail containing leucine, phenylalanine and valine (5 mM 
each). In this batch only trace amounts of luminmides were detected after 22 h of reaction. 
Figure S15 shows the results of both experiments. 
 
Figure S15. Formation of luminmide A in freshly permeabilized cells (full circles), in the presence 
of cell lysate instead of permeabilized cells (hollow squares) and in the presence of permeabilized 
cells from a previous 35 h batch (full triangles). Leucine, phenylalanine and valine concentrations 
were 5 mM each. Luminmide A was measured @ 586.4 ± 0.2 m/z. 
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V. Conclusion 
1. Summary 
The presented studies demonstrate that permeabilized cells can be used to synthesize 
metabolites like UDP-glucose and UDP-glucuronic acid which are close to the central 
metabolism. Furthermore, several natural and one synthetic nonribosomal peptide from the 
luminmide family were synthesized.The synthesis of UDP-glucose was carried out applying 
E. coli permeabilized by treatment with low (0.05% v/v) Triton X-100 concentration. In this 
case ATP and NAD
+
 were regenerated without genetic modification of the organism used. A 
system for the supply of glucose-1-phosphate from sucrose was introduced and side reactions 
were reduced by applying a phosphoglucomutase deficient strain. The final yield was 60% 
with regard to UMP. When cell lysate was used the yield was slightly lower (54%). 
For the experiments on UDP-glucuronic acid synthesis, an S. pombe strain expressing the 
human UGDH gene, was used. As the cell envelope of fission yeast is relatively robust, 0.3% 
v/v Triton X-100 were applied for 60 minutes to fully permeabilize the cells. When UDP-
glucose and NAD
+
 were supplied, the yield was 100% with respect to UDP-glucose (and 
NAD
+
). When permeabilized cells were replaced with cell lysate, no product formation was 
observed indicating the disruption or inactivation of the hexameric UGDH complex. It was 
shown that divalent cations promoted UDP-glucose hydrolysis. When 1 mM MgSO4 was 
added to the substrate mixture, the product yield did not exceed 20% while UDP-glucose was 
fully consumed. When synthesis was starting from UMP, the yield was 12%.  
To study nonribosomal peptide synthesis in permeabilized cells, an E. coli Nissle strain 
harboring the plu3263 gene cluster from Photorhabdus luminescens was used. This strain was 
fully permeabilized by treatment with 1% toluene. Luminmide synthesis was increased 
fivefold when EDTA was added to the substrate mixture. Apparent kinetics of luminmide 
synthesis was studied and values for Ks
app
 and rmax
app
 were determined. By modification of the 
substrate mixture the ratio between luminmides B and A was increased 100 fold. 
Additionally, when leucine was substituted with 4,5-dehydro-leucine in the substrate mixture, 
this unnatural amino acid was incorporated in the luminmide A structure in place of Leu 
yielding a synthetic luminmide derivative. No luminmide formation was observed when cell 
lysate was used instead of permeabilized cells. 
It is noteworthy that permeabilized cells were superior to cell lysate in each project with 
regard to product synthesis.  
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2. Concluding remarks & outlook  
2.1 Permeabilization 
Permeabilization procedures for three E. coli strains and one S. pombe strain were 
successfully established. While Triton X-100 was effective for two of the E. coli strains and 
the S. pombe strain, E. coli Nissle could not be fully permeabilized with this detergent. A trial 
and error based approach was used to determine suitable permeabilization conditions. With 
the data collected in this study a more systematic approach can be proposed. In the first phase 
the effect of Triton X-100 concentrations ranging from 0.05 to 0.5% v/v needs to be tested. 
Based on the findings presented here as well as on literature knowledge, this should be 
sufficient to permeabilize the majority of microbial cells. If Triton X-100 is not effective, it is 
generally very hard to make accurate predictions on suitable permeabilization conditions. If 
the cell membrane of the organism at hand contains high amounts of cholesterol, a treatment 
with digitonin should be attempted. Digitonin is a steroidal saponin which specifically binds 
to cholesterol. When digitonin treatment is not applicable or ineffective, other 
permeabilization agents or methods need to be used. In this step detailed studies with each 
compound are not advisable and no more than one or two different concentrations should be 
tested for each compound. Some agents are given in Table V-1. As shown in the work on S. 
pombe and E. coli Nissle, suitable permeabilization agents perform relatively well even when 
suboptimal concentrations are applied. However, non-suitable approaches are normally easy 
to identify as their performance is always significantly worse. The described procedure is 
summarized in scheme V-1. 
 
Table V-1. Some permeabilizing agents and starting concentrations at 6 g/l cell dry weight. 
Compound Concentration 
Toluene 1.5% v/v 
CTAB 0.2% m/v 
SDS 0.2% m/v 
EDTA 10 mM 
Tween 80 0.1% m/v 
N-lauroylsarcosine 1% m/v 
 
Conclusion 
 
 
82 
 
Scheme V-1. Generalized workflow for cell permeabilization. P = organism successfully 
permeabilized. NP = organism not successfully permeabilized. 
a
 Some potentially useful 
agents and concentrations are provided in table V-1 
 
As many permeabilizing agents can interfere with enzyme activity, cells need to be washed at 
least twice prior to further examination. Based on this procedure suitable permeabilization 
conditions can be determined systematically for most organisms. 
Further studies on the connection between membrane structure and permeabilization would be 
very interesting. As mentioned before, suitable permeabilization conditions can differ very 
much, even between different strains of the same species. A systematic determination of the 
underlying principles has not been carried out so far and would be an interesting topic for 
future studies. 
2.2 Comparison between in situ synthesis and in vivo and in vitro 
methods 
Generally, the in situ approach (applying permeabilized cells) can be considered an 
intermediate between in vivo and in vitro methods. In in situ synthesis, biocatalytic production 
can be directed by a careful selection of substrates. For this reason, selectivity with this 
method is a lot higher than with living cells. Additionally, byproduct formation is reduced and 
downstream processing is simplified. On the other hand, in some cases, cofactors need to be 
regenerated and more complex (and thus more expensive) substrates need to be used to reduce 
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the number of reaction steps and increase product yield. However, the in situ method is 
superior to in vivo catalysis when transport barriers like cellular membranes are limiting 
production. Even compounds that cannot penetrate the cell membrane can be applied as 
substrates in in situ processes. Additionally, non physiological substrate concentrations can be 
added to shift reaction equilibrium into the desired direction. 
When compared to in vitro synthesis, where purified enzymes are used, the in situ approach 
displays some advantages as well. The production of the biocatalyst is fast and simple. 
Freshly permeabilized cells can be produced as needed, whereas the isolation of enzymes in 
an active form is often laborious and expensive. This applies especially to enzyme complexes 
like megasynthetases, which can often not be isolated in an active form. However, isolated 
enzymes provide very high turnover rates, simultaneously working with outstanding 
selectivity. On the other hand, the enzymes stay within their natural environment when the in 
situ method is applied. This can increase catalyst stability and allows channeling, the direct 
transfer of substrates to the following enzyme in a cascade reaction (Zhang 2011).    
Overall, permeabilized cell synthesis displays several advantages compared to established 
methods. When designing production processes, the in situ approach should certainly be 
considered alongside in vivo and in vitro methods.  
2.3 Synthesis with permeabilized cells 
UDP-glucose and UDP-glucuronic acid as well as several luminmide derivatives were 
successfully synthesized in this study. Furthermore, Steffen Krauser applied permeabilized 
cells to synthesize polyketides and to regenerate cofactors (Krauser et al. 2015). It can be 
concluded that the permeabilization approach can be applied to a large variety of synthesis 
related projects. As UDP-glucose, the most prominent donor in glucosylation reactions, can 
be supplied with permeabilized cells a next step might be the production of glucosylated 
compounds. Additionally, with the ability of permeabilized cells to synthesize non ribosomal 
peptides being demonstrated, the synthesis of larger NRPs as well as depsipeptides like 
valinomycin can be attempted. The verstility of the method can be further tested by targeting 
secondary metabolites like terpenes, lantibiotics and many others. The process of synthesis 
with permeabilized cells can be divided in cell cultivation, permeabilization, biocatalytic 
product synthesis and separation of the reaction product(s) from the biocatalyst. The 
procedure is represented in Scheme V-2.  
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Scheme V-2. General procedure of synthesis using permeabilized cells. a, b and c are 
separation steps. 
In single reaction systems like the synthesis of UDP-glucuronic acid from UDP-glucose with 
S. pombe, no byproduct formation was observed. However, when more substrates were added 
to the reaction mixture, side reactions occurred and product yields were reduced. Ideally the 
permeabilization method allows control of product formation by a careful choice of 
substrates. In practice, a compromise between reaction control and complexity of the 
synthesis needs to be found. The potential of the method for large scale production of 
metabolic intermediates has been demonstrated (Koizumi et al. 2000; Koizumi et al. 1998) 
and the procedure has been applied by Kyowa Hakko Bio Co. LTD. (Japan). Here production 
was carried out in the presence of the permeabilizing agent, as the applied detergent (Nymeen 
S 215) did not hamper product formation under the applied conditions. Additionally, two 
organisms, E. coli and C. ammoniagenes, were combined in the production process. 
Nucleotides synthesized by C. ammoniagenes were directly used by E. coli to synthesize 
sugar nucleotides. Using a similar approach, large scale production processes for numerous 
metabolites using permeabilized cells may be established soon.  
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Bioinformatics tools are expected to play a crucial role in the development of permeabilized 
cell catalysts in the future. Biosynthesis using permeabilized cells can be a straightforward 
process for shorter paths or small reaction networks. It is, however, becoming increasingly 
challenging for longer biosynthetic paths with more compounds involved. The number of 
potential undesired side reactions increases dramatically, reducing product yield. Therefore, it 
is necessary to guide the design of such complex biocatalysts, by using adequate 
computational tools and the rapidly increasing information available on mostly public 
databases. An in silico tool for network topology analysis based on genome-scale metabolic 
network models to be applied for in vitro biocatalysis in cell-free systems has been proposed 
(Bujara and Panke 2012). Additionally, a tool for finding and optimizing synthesis routes in 
genome-scale metabolic networks optimized for permeabilized cells is currently under 
development by Lisa Blaß at Saarland University. While bioinformatics can help indentify 
targets for gene deletions, as well as for heterologous gene expression, a large variety of 
metabolic engineering tools is available to implement these modifications. Procedures for 
deleting genes in organisms like E. coli and C. glutamicum are well established and 
straitforward. Additionally, for E. coli, a set of strains with single gene knockouts is 
commercially available (Baba et al. 2006). The successful application of such a deletion strain 
is described is chapter II. of this thesis. Genes already present in a producer strain can be over 
expressed to increase performance. For further improvement, heterologous genes can be 
introduced. With this approach new enzymes and even whole pathways can be transferred 
into the desired organism. Heterologous gene expression is especially relevant with regard to 
secondary metabolite synthesis. Many native producers can hardly be cultured under 
laboratory conditions. By introducing the respective gene clusters into fast growing organisms 
like E. coli and P. putida, large scale production processes become possible for these 
compounds. Another way of improving or modifying a producer strain is enzyme engineering. 
By changing the amino acid sequence of enzymes, their substrate spectrum can be extended, 
cofactor requirements can be modified and relative product yields can be changed (Bian et al. 
2015; Nestl et al. 2011).  
By applying bioinformatics and metabolic engineering tools to optimize permeabilized cell 
catalysts, the full potential of the in situ approach can be exploited and a multitude of new 
possibilities will open up in the future. 
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2.4 Studies on megasynthetases with permeabilized cells 
In this study several luminmide type NRPs were synthesized. Additionally, apparent kinetics 
of luminmide A biosynthesis was determined. Traditionally, enzyme kinetics is studied in 
vitro. However, the isolation of large enzyme complexes is extremely laborious and is often 
not feasible due to the limited stability of these megasynthetases. Here permeabilized cells 
present a viable alternative. As the enzyme complexes stay within the cellular envelope, stress 
to these complexes is considerably reduced and they remain active (Krauser et al. 2015). After 
separating permeabilized cells from low molecular weight compounds (i.e. intra- and 
extracellular metabolites and medium components), substrates can be added in any desired 
combination/concentration to carry out kinetic studies. Gaining data on individual reaction 
steps like adenylation, peptidyl-transfer, condensation, epimerization or macrocyclization, 
still requires cloning of the corresponding catalytic modules. However, permeabilized cells 
can be used to study overall kinetics of megasynthetases in a straight forward manner.  
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